<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T06:12:02Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3679127" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:3679127</identifier>
        <datestamp>2013-06-17</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC3679127</article-id>
              <article-id pub-id-type="pmcid">PMC3679127</article-id>
              <article-id pub-id-type="pmc-uid">3679127</article-id>
              <article-id pub-id-type="pmid">23776431</article-id>
              <article-id pub-id-type="pmid">23776431</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-12-07053</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0063544</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v2">
                  <subject>Biology</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Enzymes</subject>
                      <subj-group>
                        <subject>Coenzyme</subject>
                      </subj-group>
                    </subj-group>
                    <subj-group>
                      <subject>Metabolism</subject>
                      <subj-group>
                        <subject>Metabolic Pathways</subject>
                      </subj-group>
                    </subj-group>
                    <subj-group>
                      <subject>Blood Chemistry</subject>
                      <subject>Cofactors</subject>
                      <subject>Small Molecules</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v2">
                  <subject>Chemistry</subject>
                  <subj-group>
                    <subject>Applied Chemistry</subject>
                    <subj-group>
                      <subject>Chemical Properties</subject>
                      <subj-group>
                        <subject>Nuclear Magnetic Resonance</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                  <subj-group>
                    <subject>Chromatography</subject>
                    <subj-group>
                      <subject>Gas Chromatography</subject>
                      <subject>Liquid Chromatography</subject>
                    </subj-group>
                  </subj-group>
                  <subj-group>
                    <subject>Organic Chemistry</subject>
                    <subj-group>
                      <subject>Organic Acids</subject>
                      <subj-group>
                        <subject>Amino Acids</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v2">
                  <subject>Medicine</subject>
                  <subj-group>
                    <subject>Diagnostic Medicine</subject>
                    <subj-group>
                      <subject>Clinical Laboratory Sciences</subject>
                      <subj-group>
                        <subject>Clinical Chemistry</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                  <subj-group>
                    <subject>Nutrition</subject>
                    <subj-group>
                      <subject>Micronutrient Deficiencies</subject>
                      <subject>Vitamins</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Metabolomic Analysis Reveals Extended Metabolic Consequences of Marginal Vitamin B-6 Deficiency in Healthy Human Subjects</article-title>
                <alt-title alt-title-type="running-head">Metabolomic Analysis of Vitamin B-6 Deficiency</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Gregory</surname>
                    <given-names>Jesse F.</given-names>
                    <suffix>III</suffix>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor1">
                    <sup>*</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Park</surname>
                    <given-names>Youngja</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="author-notes" rid="fn2">
                    <sup>¤b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lamers</surname>
                    <given-names>Yvonne</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="author-notes" rid="fn1">
                    <sup>¤a</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bandyopadhyay</surname>
                    <given-names>Nirmalya</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chi</surname>
                    <given-names>Yueh-Yun</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff4">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lee</surname>
                    <given-names>Kichen</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff5">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kim</surname>
                    <given-names>Steven</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>da Silva</surname>
                    <given-names>Vanessa</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hove</surname>
                    <given-names>Nikolas</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff5">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ranka</surname>
                    <given-names>Sanjay</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kahveci</surname>
                    <given-names>Tamer</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Muller</surname>
                    <given-names>Keith E.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff6">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Stevens</surname>
                    <given-names>Robert D.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff7">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Newgard</surname>
                    <given-names>Christopher B.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff7">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Stacpoole</surname>
                    <given-names>Peter W.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff8">
                    <sup>8</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff9">
                    <sup>9</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Jones</surname>
                    <given-names>Dean P.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">
                    <sup>2</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff1">
                <label>1</label>
                <addr-line>Food Science and Human Nutrition Department, Institute of Food and Agricultural Sciences, University of Florida, Gainesville, Florida, United States of America</addr-line>
              </aff>
              <aff id="aff2">
                <label>2</label>
                <addr-line>Clinical Biomarkers Laboratory, Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine and Center for Clinical and Molecular Nutrition, Department of Medicine, Emory University, Atlanta, Georgia, United States of America</addr-line>
              </aff>
              <aff id="aff3">
                <label>3</label>
                <addr-line>Computer and Information Science and Engineering, University of Florida, Gainesville, Florida, United States of America</addr-line>
              </aff>
              <aff id="aff4">
                <label>4</label>
                <addr-line>Department of Biostatistics, University of Florida, Gainesville, Florida, United States of America</addr-line>
              </aff>
              <aff id="aff5">
                <label>5</label>
                <addr-line>Industrial Engineering Department, Hanyang University, Seoul, Korea</addr-line>
              </aff>
              <aff id="aff6">
                <label>6</label>
                <addr-line>Department of Health Outcomes and Policy, University of Florida, Gainesville, Florida, United States of America</addr-line>
              </aff>
              <aff id="aff7">
                <label>7</label>
                <addr-line>Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, United States of America</addr-line>
              </aff>
              <aff id="aff8">
                <label>8</label>
                <addr-line>Division of Endocrinology and Metabolism, Department of Medicine, University of Florida, Gainesville, Florida, United States of America</addr-line>
              </aff>
              <aff id="aff9">
                <label>9</label>
                <addr-line>Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Tomé</surname>
                    <given-names>Daniel</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Paris Institute of Technology for Life, Food and Environmental Sciences, France</addr-line>
              </aff>
              <author-notes>
                <corresp id="cor1">* E-mail: <email>jfgy@ufl.edu</email></corresp>
                <fn fn-type="COI-statement">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <fn fn-type="con">
                  <p>Conceived and designed the experiments: JFG YL PWS. Performed the experiments: YL VdS RDS CBN YP DPJ. Analyzed the data: YP KL SK NB SR TK YYC NH KEM. Wrote the paper: JFG. Clinical oversight: PWS.</p>
                </fn>
                <fn id="fn1" fn-type="current-aff">
                  <label>¤a</label>
                  <p>Current address: Food, Nutrition and Health Program, Faculty of Land and Food Systems, University of British Columbia, Vancouver, British Columbia, Canada</p>
                </fn>
                <fn id="fn2" fn-type="current-aff">
                  <label>¤b</label>
                  <p>Current address: College of Pharmacy, Korea University, Seoul, Korea</p>
                </fn>
              </author-notes>
              <pub-date pub-type="collection">
                <year>2013</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>11</day>
                <month>6</month>
                <year>2013</year>
              </pub-date>
              <volume>8</volume>
              <issue>6</issue>
              <elocation-id>e63544</elocation-id>
              <history>
                <date date-type="received">
                  <day>2</day>
                  <month>3</month>
                  <year>2012</year>
                </date>
                <date date-type="accepted">
                  <day>5</day>
                  <month>4</month>
                  <year>2013</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2013 Gregory et al</copyright-statement>
                <copyright-year>2013</copyright-year>
                <copyright-holder>Gregory et al</copyright-holder>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p>
                </license>
              </permissions>
              <abstract>
                <p>Marginal deficiency of vitamin B-6 is common among segments of the population worldwide. Because pyridoxal 5′-phosphate (PLP) serves as a coenzyme in the metabolism of amino acids, carbohydrates, organic acids, and neurotransmitters, as well as in aspects of one-carbon metabolism, vitamin B-6 deficiency could have many effects. Healthy men and women (age: 20-40 y; n = 23) were fed a 2-day controlled, nutritionally adequate diet followed by a 28-day low-vitamin B-6 diet (&lt;0.5 mg/d) to induce marginal deficiency, as reflected by a decline of plasma PLP from 52.6±14.1 (mean ± SD) to 21.5±4.6 nmol/L (P&lt;0.0001) and increased cystathionine from 131±65 to 199±56 nmol/L (P&lt;0.001). Fasting plasma samples obtained before and after vitamin B6 restriction were analyzed by <sup>1</sup>H-NMR with and without filtration and by targeted quantitative analysis by mass spectrometry (MS). Multilevel partial least squares-discriminant analysis and S-plots of NMR spectra showed that NMR is effective in classifying samples according to vitamin B-6 status and identified discriminating features. NMR spectral features of selected metabolites indicated that vitamin B-6 restriction significantly increased the ratios of glutamine/glutamate and 2-oxoglutarate/glutamate (P&lt;0.001) and tended to increase concentrations of acetate, pyruvate, and trimethylamine-N-oxide (adjusted P&lt;0.05). Tandem MS showed significantly greater plasma proline after vitamin B-6 restriction (adjusted P&lt;0.05), but there were no effects on the profile of 14 other amino acids and 45 acylcarnitines. These findings demonstrate that marginal vitamin B-6 deficiency has widespread metabolic perturbations and illustrate the utility of metabolomics in evaluating complex effects of altered vitamin B-6 intake.</p>
              </abstract>
              <funding-group>
                <funding-statement>This study was supported by National Institutes of Health (NIH) Grant DK072398 (to Jesse F. Gregory) and NIH National Center for Research Resources CTSA Grant 1UL1RR029890. Support of the Clinical Biomarkers Laboratory, Emory University was from NIH Grant ES016731 to Dean P. Jones, and support of the Sarah W. Stedman Nutrition and Metabolism Center, Duke University, was from NIH Grant PO1-DK-58398 to Christopher B. Newgard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
              </funding-group>
              <counts>
                <page-count count="9"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <sec id="s1">
              <title>Introduction</title>
              <p>Vitamin B-6 exists in many dietary sources, yet an individual's particular food consumption pattern and certain drug-nutrient interactions can lead to low vitamin B6 status. The vitamin B-6 status of much of the United States population is adequate. However, the lower percentiles of intake are associated with low vitamin B-6 status <xref rid="pone.0063544-Morris1" ref-type="bibr">[1]</xref>, <xref rid="pone.0063544-Fulgoni1" ref-type="bibr">[2]</xref> that is more prevalent in smokers, women and the elderly <xref rid="pone.0063544-Morris1" ref-type="bibr">[1]</xref>, <xref rid="pone.0063544-Institute1" ref-type="bibr">[3]</xref>, <xref rid="pone.0063544-Centers1" ref-type="bibr">[4]</xref>. Many inflammatory conditions also are associated with lower vitamin B-6 status regardless of intake <xref rid="pone.0063544-Lotto1" ref-type="bibr">[5]</xref>, <xref rid="pone.0063544-Morris2" ref-type="bibr">[6]</xref>, but the mechanism is unknown. The use of certain common drugs such as theophylline <xref rid="pone.0063544-Ubbink1" ref-type="bibr">[7]</xref> and oral contraceptive agents <xref rid="pone.0063544-Morris1" ref-type="bibr">[1]</xref>, <xref rid="pone.0063544-Lussana1" ref-type="bibr">[8]</xref> also is associated with reduced vitamin B-6 status.</p>
              <p>The coenzymic form of vitamin B-6, pyridoxal phosphate (PLP), serves as a coenzyme for over 140 enzymes in human metabolism. PLP is thus involved in a wide array of functions <xref rid="pone.0063544-daSilva1" ref-type="bibr">[9]</xref> including: the catabolism and interconversion of most amino acids; the formation of various organic acids, including species involved in the TCA cycle and gluconeogenesis; heme synthesis; and several key steps in pathways associated with one-carbon metabolism. Vitamin B-6 deficiency also is associated with interconversions of long-chain polyunsaturated fatty acids.</p>
              <p>Plasma PLP concentration of &lt;20 nmol/L reflects vitamin B-6 deficiency <xref rid="pone.0063544-Institute1" ref-type="bibr">[3]</xref>, while 20–30 nmol/L indicates marginal status <xref rid="pone.0063544-Leklem1" ref-type="bibr">[10]</xref>, <xref rid="pone.0063544-Mackey1" ref-type="bibr">[11]</xref>. The consequences of marginal deficiency are unclear, but chronically low vitamin B6 status is associated with increased risk of cardiovascular disease <xref rid="pone.0063544-Rimm1" ref-type="bibr">[12]</xref>–<xref rid="pone.0063544-Miller1" ref-type="bibr">[17]</xref>, deep-vein thrombosis <xref rid="pone.0063544-Hron1" ref-type="bibr">[18]</xref>–<xref rid="pone.0063544-Vanuzzo1" ref-type="bibr">[20]</xref>, stroke <xref rid="pone.0063544-Kelly1" ref-type="bibr">[21]</xref> and certain cancers <xref rid="pone.0063544-Larsson1" ref-type="bibr">[22]</xref>, <xref rid="pone.0063544-Johansson1" ref-type="bibr">[23]</xref>. The mechanisms responsible for these disease connections are unknown but do not appear to be associated with hyperhomocysteinemia <xref rid="pone.0063544-Lotto1" ref-type="bibr">[5]</xref>. In view of the many coenzymic roles of PLP, further investigation of the in vivo metabolic consequences of inadequate vitamin B6 status may provide better insight into the effects of marginal vitamin B-6 deficiency.</p>
              <p>We have investigated the consequences of inadequate vitamin B6 status using a series of protocols that involve the use of controlled low-vitamin B-6 diets in healthy volunteers <xref rid="pone.0063544-Cuskelly1" ref-type="bibr">[24]</xref>–<xref rid="pone.0063544-Zhao1" ref-type="bibr">[29]</xref>. In these studies, we employed targeted metabolite profiling and in vivo stable isotope tracer kinetic protocols to derive functional information about specific vitamin-dependent processes in one-carbon metabolism and related pathways while the participants were in adequate and marginal vitamin B6 status. These studies led to the following major observations concerning the effects of vitamin B-6 restriction: (a) surprising resiliency of one-carbon metabolism to effects of vitamin B6 deficiency, (b) changes glycine kinetics and concentration, (c) the resiliency of transsulfuration flux concurrent with an expansion of the cystathionine pool, (d) individual variability in the kinetics of glutathione synthesis, and (e) altered patterns of circulating n-3 and n-6 polyunsaturated fatty acids <xref rid="pone.0063544-Cuskelly1" ref-type="bibr">[24]</xref>–<xref rid="pone.0063544-Zhao1" ref-type="bibr">[29]</xref>. This work has led to new insights into PLP-dependent metabolic processes and the influence of vitamin B6 nutritional status.</p>
              <p>Advances in both NMR and mass spectral aspects of metabolomics have impacted many facets of biology including the nutritional sciences <xref rid="pone.0063544-German1" ref-type="bibr">[30]</xref>, <xref rid="pone.0063544-Zeisel1" ref-type="bibr">[31]</xref>. The nutritional applications of NMR metabolomics to date have tended to focus on dietary effects on macronutrient metabolism and intermediary metabolites (for example, <xref rid="pone.0063544-Park1" ref-type="bibr">[32]</xref>, <xref rid="pone.0063544-Gu1" ref-type="bibr">[33]</xref>, with few applications of these powerful tools in characterizing the metabolic effects varying levels of micronutrient status (for example, <xref rid="pone.0063544-Duggan1" ref-type="bibr">[34]</xref>). The direct analysis of plasma or urine by NMR provides a useful approach that complements mass spectrometry for evaluating metabolic phenotypes associated with nutritional adequacy and deficiency and for evaluating nutrient-gene and nutrient-disease interactions.</p>
              <p>The study reported here was conducted to investigate the impact of controlled vitamin B-6 depletion through the use of <sup>1</sup>H-NMR analysis of plasma from 23 healthy participants from two recent vitamin B-6 restriction studies <xref rid="pone.0063544-Lamers1" ref-type="bibr">[27]</xref>, <xref rid="pone.0063544-Lamers2" ref-type="bibr">[28]</xref>. We examined NMR spectra of intact plasma with and without deproteination by filtration as an untargeted means of evaluating vitamin B6-dependent changes in plasma constituents. The results were evaluated using multivariate analysis accounting for the paired structure of the data to assess differences in spectral patterns and metabolite profiles. On a subset of these samples (n = 18) we also performed provisional quantification on selected metabolites by spectral curve fitting (Chenomx). Because of the critical role of vitamin B6 in the metabolism of amino acids and organic acids, we also conducted targeted metabolite profile analysis of amino acids, selected organic acids and acylcarnitines using quantitative analyses of NMR signals, and mass spectrometry.</p>
            </sec>
            <sec sec-type="materials|methods" id="s2">
              <title>Materials and Methods</title>
              <sec id="s2a">
                <title>Participants and nutritional protocols</title>
                <p>The blood samples for this study were obtained as described previously <xref rid="pone.0063544-Lamers1" ref-type="bibr">[27]</xref>, <xref rid="pone.0063544-Lamers2" ref-type="bibr">[28]</xref> from healthy men (n = 12) and women (n = 11), aged 20–40 y, who participated in two identical dietary vitamin B6 restriction protocols designed to assess the metabolic effects of marginal vitamin B6 status. Health was determined by physical examination and routine tests of hepatic, renal, thyroid and hematological function <xref rid="pone.0063544-Lamers1" ref-type="bibr">[27]</xref>, <xref rid="pone.0063544-Lamers2" ref-type="bibr">28</xref>. No participant had a history of gastrointestinal surgery, chronic disease, smoking or chronic drug use or alcoholism, body mass index <underline>not greater than</underline> 28 kg/m<sup>2</sup>, vitamin, amino acid, or protein supplementation, or chronic consumption of a high-protein diet. Nutritional adequacy was indicated normal concentrations of serum folate (greater than 7 nmol/L), serum vitamin B-12 (greater than 200 pmol/L), plasma PLP (greater than 30 nmol/L), and plasma total homocysteine (less than 12 µmol/L). All participants gave written informed consent. The study was approved by the University of Florida Institutional Review Board and the UF Clinical Research Center (CRC) Scientific Advisory Committee. This study was registered at clinicaltrials.gov as NCT00877812.</p>
                <p>The experimental protocol consisted of two dietary periods with a metabolic assessment of tracer kinetics and blood sampling for metabolite profiling at the end of each <xref rid="pone.0063544-Lamers1" ref-type="bibr">[27]</xref>, <xref rid="pone.0063544-Lamers2" ref-type="bibr">[28]</xref>. The first consisted of a 2-d nutritionally adequate controlled diet (total vitamin B-6 = 1.02±0.11 mg/d), followed by the first metabolic assessment of participants in documented adequate vitamin B6 status. The second period involved a 28-d low vitamin B-6 diet to induce a state of marginal vitamin B-6 deficiency (PLP ∼20 nmol/L), followed immediately by a metabolic assessment identical to the first. The vitamin B-6 restriction diet (total vitamin B-6 = 0.37±0.04 mg/d) provided total protein intake of 1 g kg<sup>−1</sup> d<sup>−1</sup> and mean methionine and cystine intake of 21 and 17 mg kg<sup>−1</sup> d<sup>−1</sup>, respectively. During both metabolic assessments, blood samples analyzed in this metabolomic analysis were obtained in the morning after withholding food overnight and were followed by primed, constant infusion protocols reported previously <xref rid="pone.0063544-Lamers1" ref-type="bibr">[27]</xref>, <xref rid="pone.0063544-Lamers2" ref-type="bibr">[28]</xref>. The analyses reported here were performed on plasma obtained before and after the 28-d vitamin B-6 restriction period. The samples taken for NMR and mass spectral analysis were drawn by syringe from an indwelling catheter in an antecubital vein, mixed gently in a sodium EDTA tube, cooled on ice, centrifuged within 15 min of collection and then stored at −80°C.</p>
              </sec>
              <sec id="s2b">
                <title>Targeted quantitative analysis</title>
                <p>Measurement of plasma PLP <xref rid="pone.0063544-Davis1" ref-type="bibr">[25]</xref>, <xref rid="pone.0063544-Ubbink2" ref-type="bibr">[35]</xref> and aminothiols (total glutathione, cysteine, and homocysteine; <xref rid="pone.0063544-Pfeiffer1" ref-type="bibr">[36]</xref>) was performed by fluorometric HPLC. Plasma cystathionine, a sensitive functional biomarker of vitamin B-6 deficiency <xref rid="pone.0063544-Davis2" ref-type="bibr">[26]</xref>, <xref rid="pone.0063544-Lamers1" ref-type="bibr">[27]</xref>, <xref rid="pone.0063544-Park2" ref-type="bibr">[37]</xref>), was determined by gas chromatography-mass spectrometry <xref rid="pone.0063544-Davis3" ref-type="bibr">[38]</xref>. Plasma concentrations of free amino acids and acylcarnitines were determined by electrospray tandem mass spectrometry using isotope dilution methods <xref rid="pone.0063544-Ferrara1" ref-type="bibr">[39]</xref>. We determined plasma glucose concentration using a commercial hexokinase-based assay kit (Sigma GAHK-20).</p>
              </sec>
              <sec id="s2c">
                <title>NMR analysis</title>
                <sec id="s2c1">
                  <title><sup>1</sup>H-NMR spectroscopy</title>
                  <p><sup>1</sup>H-NMR spectra were obtained at 600 MHz on a Varian INOVA 600 spectrometer with water presaturation at 25°C at the Emory University Clinical Biomarkers Laboratory, as described previously <xref rid="pone.0063544-Park1" ref-type="bibr">[32]</xref>. Plasma samples were analyzed in intact form (i.e., unfiltered) and following filtration through a 3 kD nominal cut-off membrane that removes proteins, lipids and lipoproteins as well as protein-bound forms of certain small molecules.</p>
                </sec>
                <sec id="s2c2">
                  <title>Unfiltered Plasma – <sup>1</sup>H-NMR spectroscopy</title>
                  <p>Plasma samples were thawed and 600 μL was mixed with 66 μL of deuterium oxide (D<sub>2</sub>O) with TMS [3-(trimethylsilyl)-1-propanesulfonic acid sodium salt (C<sub>6</sub>H<sub>15</sub>NaO<sub>3</sub>SSi, 1% w/w)] as internal standard, pH 7.4–7.6. <sup>1</sup>H-NMR spectra were measured at 600 MHz on a Varian INOVA 600 spectrometer with water presaturation at 25°C essentially as described <xref rid="pone.0063544-Park1" ref-type="bibr">[32]</xref>, <xref rid="pone.0063544-Park3" ref-type="bibr">[40]</xref>. Preprocessing of spectra included baseline correction, spectral alignment, elimination of uninformative spectral regions and normalization <xref rid="pone.0063544-Park1" ref-type="bibr">[32]</xref>, <xref rid="pone.0063544-Park3" ref-type="bibr">[40]</xref>, with baseline correction and peak alignment <xref rid="pone.0063544-Forshed1" ref-type="bibr">[41]</xref>, <xref rid="pone.0063544-Lee1" ref-type="bibr">[42]</xref>. The water signal region (4.5–5 ppm) was eliminated because of variable suppression of the water signal, as were the regions between 5.4–6.7 ppm and 0–0.1 ppm that contained no significant metabolite signal <xref rid="pone.0063544-Park3" ref-type="bibr">[40]</xref>, <xref rid="pone.0063544-Nicholson1" ref-type="bibr">[43]</xref>. The spectral regions containing signals from EDTA and EDTA complexes with calcium and magnesium <xref rid="pone.0063544-Barton1" ref-type="bibr">[44]</xref> also were excluded.</p>
                </sec>
                <sec id="s2c3">
                  <title>Filtered Plasma – <sup>1</sup>H-NMR spectroscopy</title>
                  <p>We examined the spectra of plasma samples following ultrafiltration, which removed most proteins, lipoproteins and lipids, in order to facilitate evaluation of small molecules. Centrifugal ultrafiltration devices (Microcon YM-3, 3,000 nominal molecular weight cutoff, Millipore Corp.) were pre-washed by centrifuging three times for 15 min each with 500 μl of portions of distilled water to remove the glycerol preservative. Each plasma sample was transferred to a pre-washed device and centrifuged at 13,800×g for 60 min. Filtered plasma samples were mixed with TMS and adjusted pH 7.0–7.4. 1H-NMR spectra were acquired at 600 MHz on a Varian INOVA 600 spectrometer with water presaturation at 25°C as described above. As described for previous 1H-NMR studies of human plasma conducted by the Emory Clinical Biomarkers Laboratory <xref rid="pone.0063544-Park1" ref-type="bibr">[32]</xref>, the identity of major signals was supported by the addition of standards (amino acids, organic acids, energy intermediates), comparisons to spectra in chemical databases, reference to a rigorous description of NMR spectra of human plasma <xref rid="pone.0063544-Nicholson1" ref-type="bibr">[43]</xref>, application of the Chenomx database, and confirmation with 2-dimensional (2-D) NMR techniques.</p>
                </sec>
                <sec id="s2c4">
                  <title>Quantitative <sup>1</sup>H-NMR analysis of metabolites</title>
                  <p>The analysis of NMR spectra from filtered samples utilizing spectral fitting techniques (Chenomx, Edmonton, Alberta, Canada) allowed estimation of the concentrations of major plasma constituent small molecules <xref rid="pone.0063544-Weljie1" ref-type="bibr">[45]</xref>, <xref rid="pone.0063544-Weljie2" ref-type="bibr">[46]</xref>. For 5 of the 23 participants, at least one of the NMR spectra did not meet the criteria needed for the Chenomx analysis. Therefore, quantitative analysis is reported only on the 18 participants for which pre- and post-vitamin B-6 restriction data were obtained. We report from this analysis estimates of the concentrations of 15 plasma constituents for these 18 participants before and after vitamin B-6 restriction.</p>
                </sec>
              </sec>
              <sec id="s2d">
                <title>Data analysis</title>
                <p>Principal Component Analysis (PCA) and Orthogonal Signal Correction-Partial Least Squares Discriminant Analysis (OPLS-DA) of processed spectra were performed using Pirouette software (Infometrix, Bothell, WA). PCA and OPLS-DA score plots and loading plots of NMR spectral data were used to visualize relational patterns and discriminatory factors to classify the groups. The OPLS-DA procedure, being a supervised technique (i.e., treatment groupings included in the analysis), removes variation not correlated to classification after centering the mean value for each frequency <xref rid="pone.0063544-Gu1" ref-type="bibr">[33]</xref>, <xref rid="pone.0063544-Park3" ref-type="bibr">[40]</xref>, <xref rid="pone.0063544-Walsh1" ref-type="bibr">[47]</xref>. Data were evaluated for unfiltered and filtered plasma using score plots in OPLS-DA analysis to evaluate the classification according to vitamin B-6 status. For each discriminating spectral region, we assigned the compounds that possibly contributed on the basis of previous literature <xref rid="pone.0063544-Nicholson1" ref-type="bibr">[43]</xref>, experiments involving the addition of selected standards, comparison to spectra in databases or applications with 2-dimensional NMR procedures <xref rid="pone.0063544-Park1" ref-type="bibr">[32]</xref>, <xref rid="pone.0063544-Park3" ref-type="bibr">[40]</xref>.</p>
                <p>To account for the paired data structure within our study (i.e., observations before and after vitamin B-6 restriction), we then conducted multilevel PLS-DA as described by Westerhuis et al. <xref rid="pone.0063544-Davis3" ref-type="bibr">[38]</xref> as follows. First, the paired structure was created by averaging each ppm for all individual spectra including B6 baseline and restricted. From each individual, the average spectrum were created with B6 baseline and restricted. Secondly, for each subject, the table of correction factors for each ppm was extracted by dividing averaged intensity at each ppm from all individual spectra with averaged intensity at each ppm from each individual averaged spectrum. Thirdly, using correction factors for each ppm, the intensities for each B6 baseline and restricted were adjusted to generate paired data structure. Lastly OPLS-DA was run on the paired data structure. Additonal analysis to identify and visualize discriminatory spectral regions was conducted using S-plots of covariance versus correlation for spectral data <xref rid="pone.0063544-Wiklund1" ref-type="bibr">[48]</xref> followed by loading plots of covariance versus chemical shift on mean spectra. After calculation of the top 5% of discriminatory loadings in this analysis (647 and 381 for unfiltered and filtered plasma, respectively), we visually selected points (65 and 26 for unfiltered and filtered, respectively) in regions of the S-plots that were clearly separated from the central risk zone. These represented the most highly discriminating features.</p>
                <p>Further statistical analysis of metabolite concentrations was performed after log base 2 transformation using a recently developed method for global hypothesis testing in repeated measures high-dimensional data <xref rid="pone.0063544-Chi1" ref-type="bibr">[49]</xref>. The log base 2 transformation was a means to meet the Gaussian requirement. For subsequent local hypothesis testing, we evaluated differences in the transformed concentration of individual plasma constituents using paired t-test and the positive false discovery rate method <xref rid="pone.0063544-Storey1" ref-type="bibr">[50]</xref> to adjust p-values in anticipation of the inflation of false positive rate as a result of multiple testing. The effects of change in plasma PLP and change in plasma cystathionine were evaluated using the test for Pearson correlation coefficient in conjunction with the positive false discovery rate method to account for multiple testing.</p>
                <p>Ratios of selected metabolites derived from NMR analysis were evaluated to assess product/precursor relationships before and after vitamin B-6 restriction. Asparagine/aspartic acid and pyruvate/alanine ratios served as static indicators of the proportions of amide versus acid forms of glutamate and aspartate. The ratios of pyruvate/alanine and 2-oxoglutarate/glutamate provided a measure of the product/precursor ratio for these aminotransferases.</p>
                <p>A level of statistical significance of 0.05 was employed in all procedures.</p>
              </sec>
            </sec>
            <sec id="s3">
              <title>Results</title>
              <sec id="s3a">
                <title>Efficacy of the vitamin B-6 restriction protocol</title>
                <p>The dietary protocol provided a controlled, nutritionally adequate 2-day stabilization period followed by very low vitamin B-6 intake for 28 days, and this protocol is effective for selectively inducing a state of marginal vitamin B-6 deficiency in healthy adults <xref rid="pone.0063544-Davis1" ref-type="bibr">[25]</xref>, <xref rid="pone.0063544-Lamers3" ref-type="bibr">[51]</xref>, <xref rid="pone.0063544-Lamers4" ref-type="bibr">[52]</xref>. Plasma PLP concentration declined from 52.6±14.1 (mean ± SD) to 21.5±4.6 nmol/L (P&lt;0.0001), which indicated a change from adequate vitamin B-6 status to marginal deficiency. Additional descriptive data regarding the 23 participants in this protocol have been reported in part previously <xref rid="pone.0063544-Lamers1" ref-type="bibr">[27]</xref>–<xref rid="pone.0063544-Zhao1" ref-type="bibr">[29]</xref> and are summarized (<xref ref-type="supplementary-material" rid="pone.0063544.s002">Table S1</xref>).</p>
              </sec>
              <sec id="s3b">
                <title>Metabolic effects of vitamin B-6 restriction</title>
                <sec id="s3b1">
                  <title>Global statistical analysis of <sup>1</sup>H NMR spectral data</title>
                  <p><sup>1</sup>H-NMR analysis of plasma samples yielded spectra that were qualitatively similar to those originally reported and annotated by Nicholson and colleagues <xref rid="pone.0063544-Nicholson1" ref-type="bibr">[43]</xref>, <xref rid="pone.0063544-Solanky1" ref-type="bibr">[53]</xref>. Filtration of plasma attenuated the regions of the spectrum attributable to lipids and proteins, as expected. Representative spectra of unfiltered and filtered plasma in vitamin B-6 adequate and restricted states are presented in <xref ref-type="supplementary-material" rid="pone.0063544.s001">Figure S1</xref>.</p>
                  <p>Statistical evaluation of spectra first involved assessing the change in overall spectral data (before versus after vitamin B-6 restriction) using a recent method for global hypothesis testing for high-dimensional repeated measures outcomes of pairwise data <xref rid="pone.0063544-Chi1" ref-type="bibr">[49]</xref>. By this method, the overall change across the entire spectrum was not significant for unfiltered plasma (p-value = 0.432) and filtered plasma (p-value = 0.549). Gender also had no significant effect on the overall change in spectra of unfiltered plasma (p-value = 0.683) or filtered plasma (p-value = 0.275) in this analysis. Because this n = 23 data set was derived from two equivalent vitamin B-6 restriction trials, we also tested for effects of trial 1 versus trial 2. The effect of trial (1 versus 2) had no significant effect on the overall change for unfiltered plasma (p-value = 0.103) or filtered plasma (p-value = 0.346).</p>
                </sec>
                <sec id="s3b2">
                  <title>Multilevel PLS-DA evaluation of <sup>1</sup>H-NMR spectra to assess effects of vitamin B-6 restriction in paired data</title>
                  <p>Principal Component Analysis that did not account for paired structure of the spectral data obtained before and after vitamin B-6 restriction showed no separation or grouping of data according to vitamin B-6 status for both unfiltered and filtered plasma (data not shown). OPLS-DA, which is a supervised technique in which treatment groupings are identified, yielded unambiguous classification of data patterns according to nutritional status (i.e., pre- and post-vitamin B-6 restriction) for both unfiltered and filtered plasma (not shown). This provided evidence of extended compositional differences associated with vitamin B-6 restriction, although the OPLS-DA method also did not account for the paired data structure.</p>
                  <p>Multilevel PLS-DA <xref rid="pone.0063544-Westerhuis1" ref-type="bibr">[54]</xref>, which is an approach to multivariate analysis that incorporates provisions for paired data, showed distinct separation according to vitamin B-6 status in both unfiltered and filtered plasma (<xref ref-type="fig" rid="pone-0063544-g001">Figure 1</xref>). For unfiltered plasma, the first orthogonal component (40% of total variation) and the first principal components explained 40% and 30% of the total variation, respectively. For filtered plasma the first orthogonal component and the first principal component explained 29% and 60% of total variation, respectively. S-plots derived from this analysis of<sup>1</sup>H-NMR data in the multilevel PLS-DA allowed detection of the spectral regions that discriminated between vitamin B-6 adequacy (baseline) and restricted conditions for both filtered and unfiltered plasma (<xref ref-type="fig" rid="pone-0063544-g002">Figure 2A and 2B</xref>). When discriminating features were superimposed on mean spectra (<xref ref-type="fig" rid="pone-0063544-g002">Figure 2C and 2D</xref>), the discriminating regions appeared to be primarily attributable to lipids, organic acids and amino acids for unfiltered plasma and organic acids, and amino acids for filtered plasma (<xref ref-type="fig" rid="pone-0063544-g002">Figure 2C and 2D</xref>).</p>
                  <fig id="pone-0063544-g001" orientation="portrait" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0063544.g001</object-id>
                    <label>Figure 1</label>
                    <caption>
                      <title>Metabolic patterns separated adequate vitamin B6 at baseline from marginally deficient status after 4 weeks on a restricted diet.</title>
                      <p>Plasma samples from 23 healthy, young adults collected at baseline and after 4 weeks consuming a vitamin B6-restricted diet were examined by <sup>1</sup>H-NMR spectroscopy followed by multilevel partial least square-discriminant analysis (multilevel PLS-DA). A) Score plot for unfiltered plasma, which contains relatively large signal from lipoproteins. B) Score plot for plasma filtered through a 3 μm pore size filter to remove most of the lipoprotein before <sup>1</sup>H-NMR spectroscopy analysis.</p>
                    </caption>
                    <graphic xlink:href="pone.0063544.g001"/>
                  </fig>
                  <fig id="pone-0063544-g002" orientation="portrait" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0063544.g002</object-id>
                    <label>Figure 2</label>
                    <caption>
                      <title>S-plots from multilevel PLS-DA show that <sup>1</sup>H-NMR signals from many metabolites contribute to separation of vitamin B6 adequate and vitamin B6 restricted conditions.</title>
                      <p>Panels A and B: S-plots that respectively correspond with the score plots in <xref ref-type="fig" rid="pone-0063544-g001">Figure 1A</xref> (Not Filtered) and <xref ref-type="fig" rid="pone-0063544-g001">Figure 1B</xref> (Filtered) plasma. In these panels, the top 5% of metabolites that contribute to 95% of the separation of baseline and restricted samples are highlighted in red squares. Red-framed points within the ovals represent the most highly discriminating signals. Panels C and D: loading plots illustrating discriminating spectral features from S-plots. Covariance of each discriminating feature is superimposed on the corresponding NMR chemical shift on mean spectra.</p>
                    </caption>
                    <graphic xlink:href="pone.0063544.g002"/>
                  </fig>
                </sec>
                <sec id="s3b3">
                  <title>Vitamin B-6 restriction affects the plasma metabolite profile</title>
                  <p>Analysis using NMR spectral fitting provided an estimation of the concentration of selected plasma constituents for which methods of targeted quantitative analysis were not readily available in this study. We report here this analysis using Chenomx software for acetate, acetoacetate, aspartate, asparagine, choline, formate, fumarate, glutamate, glutamine, lactate, myo-inositol, 2-oxoglutarate, pyruvate, succinate taurine and trimethylamine oxide in a subset (n = 18) of the participants (<xref ref-type="table" rid="pone-0063544-t001">Table 1</xref>). Local hypothesis testing of changes in the estimated plasma concentrations derived from spectral features attributed to acetate, asparagine, glutamine, myo-inositol, lactate, 2-oxoglutarate, pyruvate, taurine and trimethylamine-N-oxide significantly increased (adjusted P&lt;0.05), while that of glutamate significantly decreased (adjusted P&lt;0.05) (<xref ref-type="table" rid="pone-0063544-t001">Table 1</xref>).</p>
                  <table-wrap id="pone-0063544-t001" orientation="portrait" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0063544.t001</object-id>
                    <label>Table 1</label>
                    <caption>
                      <title>Estimated concentration of selected plasma constituents before and after vitamin B-6 restriction determined in filtered plasma by Chenomx spectral fitting analysis of <xref ref-type="table-fn" rid="nt101">1</xref>H-NMR.</title>
                    </caption>
                    <alternatives>
                      <graphic id="pone-0063544-t001-1" xlink:href="pone.0063544.t001"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" span="1"/>
                          <col align="center" span="1"/>
                          <col align="center" span="1"/>
                          <col align="center" span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Variable</td>
                            <td align="left" rowspan="1" colspan="1">Baseline</td>
                            <td align="left" rowspan="1" colspan="1">Vitamin B-6 Restricted</td>
                            <td align="left" rowspan="1" colspan="1">
                              <italic>Adjusted P</italic>
                              <xref ref-type="table-fn" rid="nt102">2</xref>
                            </td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1"/>
                            <td align="left" rowspan="1" colspan="1">
                              <italic>mmol/L</italic>
                            </td>
                            <td align="left" rowspan="1" colspan="1"/>
                            <td align="left" rowspan="1" colspan="1"/>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Acetate</td>
                            <td align="left" rowspan="1" colspan="1">56±23</td>
                            <td align="left" rowspan="1" colspan="1">79±49*</td>
                            <td align="left" rowspan="1" colspan="1">0.028</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Acetoacetate</td>
                            <td align="left" rowspan="1" colspan="1">49±38</td>
                            <td align="left" rowspan="1" colspan="1">42±28</td>
                            <td align="left" rowspan="1" colspan="1">0.493</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Acetone</td>
                            <td align="left" rowspan="1" colspan="1">36±32</td>
                            <td align="left" rowspan="1" colspan="1">39±27</td>
                            <td align="left" rowspan="1" colspan="1">0.317</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Asparagine</td>
                            <td align="left" rowspan="1" colspan="1">50±23</td>
                            <td align="left" rowspan="1" colspan="1">75±33*</td>
                            <td align="left" rowspan="1" colspan="1">0.011</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Aspartate</td>
                            <td align="left" rowspan="1" colspan="1">49±27</td>
                            <td align="left" rowspan="1" colspan="1">63±30</td>
                            <td align="left" rowspan="1" colspan="1">0.055</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Choline</td>
                            <td align="left" rowspan="1" colspan="1">36±33</td>
                            <td align="left" rowspan="1" colspan="1">37±24</td>
                            <td align="left" rowspan="1" colspan="1">0.448</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Formate</td>
                            <td align="left" rowspan="1" colspan="1">61±18</td>
                            <td align="left" rowspan="1" colspan="1">79±48</td>
                            <td align="left" rowspan="1" colspan="1">0.158</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Glutamate</td>
                            <td align="left" rowspan="1" colspan="1">78±37</td>
                            <td align="left" rowspan="1" colspan="1">61±26*</td>
                            <td align="left" rowspan="1" colspan="1">0.011</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Glutamine</td>
                            <td align="left" rowspan="1" colspan="1">130±150</td>
                            <td align="left" rowspan="1" colspan="1">205±201*</td>
                            <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Myo-Inositol</td>
                            <td align="left" rowspan="1" colspan="1">23±12</td>
                            <td align="left" rowspan="1" colspan="1">39±21*</td>
                            <td align="left" rowspan="1" colspan="1">0.011</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">2-Oxoglutarate</td>
                            <td align="left" rowspan="1" colspan="1">37±14</td>
                            <td align="left" rowspan="1" colspan="1">51±21*</td>
                            <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Pyruvate</td>
                            <td align="left" rowspan="1" colspan="1">94±54</td>
                            <td align="left" rowspan="1" colspan="1">121±61*</td>
                            <td align="left" rowspan="1" colspan="1">0.028</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Succinate</td>
                            <td align="left" rowspan="1" colspan="1">26±13</td>
                            <td align="left" rowspan="1" colspan="1">30±16</td>
                            <td align="left" rowspan="1" colspan="1">0.305</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Trimethylamine-N-oxide</td>
                            <td align="left" rowspan="1" colspan="1">9±10</td>
                            <td align="left" rowspan="1" colspan="1">17±16*</td>
                            <td align="left" rowspan="1" colspan="1">0.004</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Urea</td>
                            <td align="left" rowspan="1" colspan="1">1250± 1180</td>
                            <td align="left" rowspan="1" colspan="1">1130±884</td>
                            <td align="left" rowspan="1" colspan="1">0.493</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                    <table-wrap-foot>
                      <fn id="nt101">
                        <label>1</label>
                        <p>Mean ± SD, n = 18. Concentrations approximated from the respective singlet resonances using Chenomx spectral fitting analysis.</p>
                      </fn>
                      <fn id="nt102">
                        <label>2</label>
                        <p>Adjusted P-value through controlling positive FDR after paired t-tests on changes on log2 transformed concentrations.* designates significant difference at P&lt;0.05. The effect of vitamin B-6 restriction on the overall pattern of constituents in Chenomx analysis was significant in multivariate testing, P = 5.3×10<sup>−7</sup>.</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                  <p>The evaluation of the ratios of several of these plasma constituents allowed us to probe possible biochemical effects of vitamin B-6 restriction. Whereas spectral features attributable to asparagine and glutamine concentrations increased (<xref ref-type="table" rid="pone-0063544-t001">Table 1</xref>), the ratios reflecting the relative extent of amidation differed (<xref ref-type="table" rid="pone-0063544-t002">Table 2</xref>). Vitamin B-6 restriction did not significantly change the asparagine/aspartate ratio, but the ratio of glutamine/glutamate more than doubled due to the restriction (P&lt;0.001). In addition, the ratio of the 2-ketoacids pyruvate and 2-oxoglutarate and the corresponding amino acids alanine and glutamate reflected the balance of respective aminotransferase reactions. The pyruvate/alanine ratio did not change significantly, while the 2-ketoglutarate/glutamate ratio increased 76% due to vitamin B-6 restriction (P&lt;0.001). The ratio of plasma lactate/pyruvate, which is indicative of cytoplasmic redox state and cellular respiration, did not change due to vitamin B-6 restriction (8.3±2.0 versus 7.6±1.5; P = 0.242).</p>
                  <table-wrap id="pone-0063544-t002" orientation="portrait" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0063544.t002</object-id>
                    <label>Table 2</label>
                    <caption>
                      <title>Ratios of selected plasma constituents determined in filtered plasma by <xref ref-type="table-fn" rid="nt103">1</xref>H-NMR, before and after vitamin B-6 restriction.</title>
                    </caption>
                    <alternatives>
                      <graphic id="pone-0063544-t002-2" xlink:href="pone.0063544.t002"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" span="1"/>
                          <col align="center" span="1"/>
                          <col align="center" span="1"/>
                          <col align="center" span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Variables</td>
                            <td align="left" rowspan="1" colspan="1">Baseline</td>
                            <td align="left" rowspan="1" colspan="1">Vitamin B-6 Restricted</td>
                            <td align="left" rowspan="1" colspan="1">
                              <italic>P</italic>
                            </td>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td colspan="4" align="left" rowspan="1">
                              <underline>Transamination ratios</underline>
                            </td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Pyruvate/Alanine</td>
                            <td align="left" rowspan="1" colspan="1">0.280±0.093</td>
                            <td align="left" rowspan="1" colspan="1">0.296±0.095</td>
                            <td align="left" rowspan="1" colspan="1">0.554</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">2-Oxoglutarate/Glutamate</td>
                            <td align="left" rowspan="1" colspan="1">0.556±0.303</td>
                            <td align="left" rowspan="1" colspan="1">0.984±0.582*</td>
                            <td align="left" rowspan="1" colspan="1">0.001</td>
                          </tr>
                          <tr>
                            <td colspan="4" align="left" rowspan="1">
                              <underline>Amidation ratios</underline>
                            </td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Asparagine/Aspartate</td>
                            <td align="left" rowspan="1" colspan="1">1.20±0.56</td>
                            <td align="left" rowspan="1" colspan="1">1.39±0.66</td>
                            <td align="left" rowspan="1" colspan="1">0.250</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Glutamine/Glutamate</td>
                            <td align="left" rowspan="1" colspan="1">1.42±1.23</td>
                            <td align="left" rowspan="1" colspan="1">3.17±2.76*</td>
                            <td align="left" rowspan="1" colspan="1">0.001</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                    <table-wrap-foot>
                      <fn id="nt103">
                        <label>1</label>
                        <p>Mean ± SD, n = 18.</p>
                      </fn>
                      <fn id="nt104">
                        <label>2</label>
                        <p><italic>P</italic> value determined by paired t-test after log<sub>2</sub> transformation. * designates a significant difference at P&lt;0.05.</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                  <p>The concentration of amino acids and glutathione determined by targeted quantitative methods (tandem mass spectrometry, GC-MS and HPLC) revealed significant effects of vitamin B-6 restriction (<xref ref-type="table" rid="pone-0063544-t003">Table 3</xref>). Plasma cystathionine, which is a functional biomarker of vitamin B-6 deficiency indicating functional impairment of the transsulfuration pathway <xref rid="pone.0063544-Lamers1" ref-type="bibr">[27]</xref>, <xref rid="pone.0063544-Park2" ref-type="bibr">[37]</xref>, <xref rid="pone.0063544-Davis3" ref-type="bibr">[38]</xref>, increased markedly (adjusted P = 0.0002). Plasma proline exhibited an unexpected increase (adjusted P&lt;0.05), but there was no significant change in most of the other amino acids evaluated (alanine, arginine, asx, citrulline, glx, glycine, histidine, leucine + isoleucine, methionine, ornithine, phenylalanine, serine, tyrosine, and valine). In this context, asx and glx refer to the concentrations of aspartate and glutamate plus a contribution from partial hydrolysis of their amides, asparagine and glutamine, under the conditions of the tandem mass spectral analysis. The concentration of plasma glucose measured enzymatically was not changed by vitamin B-6 restriction (4.71±0.676 versus 4.52±0.543 mmol/L; adjusted P = 0.122). We found no change in the concentrations of 45 acylcarnitines or in total acylcarnitines (<xref ref-type="supplementary-material" rid="pone.0063544.s003">Table S2</xref>).</p>
                  <table-wrap id="pone-0063544-t003" orientation="portrait" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0063544.t003</object-id>
                    <label>Table 3</label>
                    <caption>
                      <title>Concentration of plasma free amino acids and glutathione determined by targeted quantitative methods before and after vitamin B-6 restriction.<xref ref-type="table-fn" rid="nt105">1</xref>
</title>
                    </caption>
                    <alternatives>
                      <graphic id="pone-0063544-t003-3" xlink:href="pone.0063544.t003"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" span="1"/>
                          <col align="center" span="1"/>
                          <col align="center" span="1"/>
                          <col align="center" span="1"/>
                          <col align="center" span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Variable</td>
                            <td align="left" rowspan="1" colspan="1">Method</td>
                            <td align="left" rowspan="1" colspan="1">Baseline</td>
                            <td align="left" rowspan="1" colspan="1">Vitamin B-6 Restricted</td>
                            <td align="left" rowspan="1" colspan="1">
                              <italic>Adjusted P</italic>
                              <xref ref-type="table-fn" rid="nt106">2</xref>
                            </td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1"/>
                            <td align="left" rowspan="1" colspan="1"/>
                            <td align="left" rowspan="1" colspan="1">
                              <italic>µmol/L</italic>
                            </td>
                            <td align="left" rowspan="1" colspan="1">
                              <italic>µmol/L</italic>
                            </td>
                            <td align="left" rowspan="1" colspan="1"/>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Alanine</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">377±112</td>
                            <td align="left" rowspan="1" colspan="1">396±77</td>
                            <td align="left" rowspan="1" colspan="1">0.281</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Arginine</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">94±26</td>
                            <td align="left" rowspan="1" colspan="1">86±17</td>
                            <td align="left" rowspan="1" colspan="1">0.281</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Asx</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">77±21</td>
                            <td align="left" rowspan="1" colspan="1">74±16</td>
                            <td align="left" rowspan="1" colspan="1">0.577</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Citrulline</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">33±10</td>
                            <td align="left" rowspan="1" colspan="1">34±9</td>
                            <td align="left" rowspan="1" colspan="1">0.577</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Cystathionine</td>
                            <td align="left" rowspan="1" colspan="1">GC-MS</td>
                            <td align="left" rowspan="1" colspan="1">131±65</td>
                            <td align="left" rowspan="1" colspan="1">199±56*</td>
                            <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Cysteine (total)</td>
                            <td align="left" rowspan="1" colspan="1">HPLC</td>
                            <td align="left" rowspan="1" colspan="1">256±39</td>
                            <td align="left" rowspan="1" colspan="1">253±36</td>
                            <td align="left" rowspan="1" colspan="1">0.577</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Glx</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">73±24</td>
                            <td align="left" rowspan="1" colspan="1">82±32</td>
                            <td align="left" rowspan="1" colspan="1">0.281</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Glutathione (total)</td>
                            <td align="left" rowspan="1" colspan="1">HPLC</td>
                            <td align="left" rowspan="1" colspan="1">7.17±1.84</td>
                            <td align="left" rowspan="1" colspan="1">7.15±1.26</td>
                            <td align="left" rowspan="1" colspan="1">0.855</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Glycine</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">357±83</td>
                            <td align="left" rowspan="1" colspan="1">393±95</td>
                            <td align="left" rowspan="1" colspan="1">0.281</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Histidine</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">82±13</td>
                            <td align="left" rowspan="1" colspan="1">77±18</td>
                            <td align="left" rowspan="1" colspan="1">0.281</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Homocysteine (total)</td>
                            <td align="left" rowspan="1" colspan="1">HPLC</td>
                            <td align="left" rowspan="1" colspan="1">6.97±1.26</td>
                            <td align="left" rowspan="1" colspan="1">6.97±1.33</td>
                            <td align="left" rowspan="1" colspan="1">0.925</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Leucine/Isoleucine</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">158±31</td>
                            <td align="left" rowspan="1" colspan="1">154±27</td>
                            <td align="left" rowspan="1" colspan="1">0.577</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Methionine</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">25±6</td>
                            <td align="left" rowspan="1" colspan="1">26±6</td>
                            <td align="left" rowspan="1" colspan="1">0.724</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Ornithine</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">47±11</td>
                            <td align="left" rowspan="1" colspan="1">49±12</td>
                            <td align="left" rowspan="1" colspan="1">0.483</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Phenylalanine</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">78±21</td>
                            <td align="left" rowspan="1" colspan="1">74±19</td>
                            <td align="left" rowspan="1" colspan="1">0.281</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Proline</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">190±90</td>
                            <td align="left" rowspan="1" colspan="1">223±84*</td>
                            <td align="left" rowspan="1" colspan="1">0.004</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Serine</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">115±24</td>
                            <td align="left" rowspan="1" colspan="1">125±33</td>
                            <td align="left" rowspan="1" colspan="1">0.281</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Tyrosine</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">75±17</td>
                            <td align="left" rowspan="1" colspan="1">71±13</td>
                            <td align="left" rowspan="1" colspan="1">0.329</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Valine</td>
                            <td align="left" rowspan="1" colspan="1">Tandem MS</td>
                            <td align="left" rowspan="1" colspan="1">196±34</td>
                            <td align="left" rowspan="1" colspan="1">190±29</td>
                            <td align="left" rowspan="1" colspan="1">0.565</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                    <table-wrap-foot>
                      <fn id="nt105">
                        <label>1</label>
                        <p>Mean ± SD, n = 23.</p>
                      </fn>
                      <fn id="nt106">
                        <label>2</label>
                        <p>Adjusted P-value through controlling positive FDR after paired t-tests on changes on log2 transformed concentrations. * designates significant difference at P&lt;0.05. The effect of vitamin B-6 restriction on the overall pattern of constituents was significant in multivariate testing, <italic>P</italic> = 0.0296.</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                  <p>We also evaluated whether the change in the various quantified plasma constituents was related to the change in plasma PLP concentration. No significant relationship with PLP was found for the amino acids and glutathione (adjusted P = 0.764) or for the acylcarnitines (adjusted P = 0.747).</p>
                </sec>
              </sec>
            </sec>
            <sec id="s4">
              <title>Discussion</title>
              <sec id="s4a">
                <title>Effectiveness of the vitamin B-6 restriction protocol</title>
                <p>The controlled vitamin B-6 restriction protocol employed in this study provided a novel and reproducible tool for investigating metabolic effects of marginally deficient vitamin B-6 status <xref rid="pone.0063544-Cuskelly1" ref-type="bibr">[24]</xref>–<xref rid="pone.0063544-Lamers2" ref-type="bibr">[28]</xref>. We recognize, however, that the short term metabolic effects of marginal vitamin B-6 status may not reflect the mechanisms responsible for the association of chronic low vitamin B-6 status with greater long-term risk of various forms of chronic disease. We also recognize that subtle differences between the controlled diet and the previous self-selected diet of the participants could contribute to observed metabolite patterns. This protocol constituted an opportunity in which to investigate the utility of metabolomic approaches in the context of controlled low vitamin B-6 status over a relatively brief period. To our knowledge, this is the first report of the use of combined global and targeted metabolomic approaches for probing micronutrient deficiency of any type.</p>
              </sec>
              <sec id="s4b">
                <title>Metabolomic tools in vitamin B-6 research</title>
                <p>The combined NMR and targeted mass spectral analysis in this study yielded new insights into the metabolic effects of vitamin B-6 restriction. They also indicate the merits of concurrently using NMR and mass spectrometry in nutritional metabolomics. <sup>1</sup>H-NMR has several analytical strengths when investigating micronutrient status. First, NMR can detect differences in overall plasma composition in both whole (unfiltered) plasma and following filtration to remove most proteins, lipids and lipoproteins. Minimal sample preparation is required, and aspects of the procedure are suitable for automation. Second, because of the comparatively low sensitivity of <sup>1</sup>H-NMR (relative to mass spectrometry-based procedures), the spectra reflect the metabolic phenotype at the level of macronutrients and their metabolites. This provides a particularly useful tool in evaluating the widespread effects of its micronutrient restriction on human metabolism. The focus of <sup>1</sup>H-NMR on relatively high-concentration plasma constituents, such as amino acids and organic acids, yields a broad assessment of the direct and indirect effects of vitamin B-6 restriction on human intermediary metabolism. Third, our results show that <sup>1</sup>H-NMR has potential as a diagnostic technique that compliments conventional analysis of a single biomarker (e.g., plasma PLP) in characterizing marginal vitamin B-6 deficiency. Further investigation will be needed to validate this diagnostic application more fully.</p>
                <p>Based on the current data, the sensitivity and specificity of multilevel PLS-DA of NMR spectra in reflecting overall metabolic effects of vitamin B-6 restriction are excellent. The minimal sample preparation needed for NMR analysis preserves the patterns of labile compounds such as asparagine and glutamine. However, the estimation of metabolite concentrations by spectral fitting using techniques such as illustrated here with Chenomx software should not be viewed as quantitatively conclusive. Confirmatory targeted analysis should be conducted wherever possible, especially for these metabolites in which changes are subtle. In the case of free amino acids such as asparagine, aspartate, glutamate and glutamine, differences between NMR-based and targeted mass spectrometry-based analyses may partially be attributable to NMR response to amino acid residues in the plasma peptides <xref rid="pone.0063544-Aristoteli1" ref-type="bibr">[55]</xref> that would be present in the ultrafiltrates used in NMR-Chenomx analysis. Other sources of variability in metabolite quantification by spectral fitting have been reported <xref rid="pone.0063544-Tredwell1" ref-type="bibr">[56]</xref>.</p>
              </sec>
              <sec id="s4c">
                <title>Metabolic consequences of vitamin B-6 restriction</title>
                <p>Because pyridoxal phosphate serves a coenzymatic function in over 140 reactions, the potential for metabolic effects of vitamin B-6 deficiency extends broadly through many phases of human metabolism. As illustrated by our previous studies involving the transsulfuration enzymes cystathionine β-synthase and cystathionine γ-lyase <xref rid="pone.0063544-Davis2" ref-type="bibr">[26]</xref>, <xref rid="pone.0063544-Lamers2" ref-type="bibr">[28]</xref>, PLP binding affinity is not fully informative of impairment caused by vitamin B-6 restriction. Broadly focused metabolite profiling methods allow one to assess more fully the extended effects of a nutritional condition, such as marginal vitamin B-6 deficiency.</p>
                <p>Many reactions of the interconversion and catabolism of amino acids require PLP. PLP-dependent aspects of one-carbon metabolism (cytoplasmic and mitochondrial serine hydroxymethyltransferases and the mitochondrial glycine cleavage system) that regulate these amino acids play an important role in the supply and balance of 1C units in metabolism <xref rid="pone.0063544-Davis1" ref-type="bibr">[25]</xref>, <xref rid="pone.0063544-Lamers1" ref-type="bibr">[27]</xref>. Applications of in vivo stable isotopic tracer kinetics and mathematical modeling have shown situations in which in vivo fluxes of PLP-dependent processes and substrate/product concentrations are not totally predicted by vitamin B-6 status. For example, although the in vitro activities of cytoplasmic serine hydroxymethyltransferase (SHMT) and mitochondrial SHMT are strongly influenced by vitamin B-6 status <xref rid="pone.0063544-Davis1" ref-type="bibr">[25]</xref>, <xref rid="pone.0063544-Scheer1" ref-type="bibr">[57]</xref>, in vivo SHMT flux is relatively resilient to marginal deficiency <xref rid="pone.0063544-Davis1" ref-type="bibr">[25]</xref>, <xref rid="pone.0063544-Nijhout1" ref-type="bibr">[58]</xref>. Likewise, overall transsulfuration flux and cysteine production are maintained during marginal vitamin B-6 deficiency <xref rid="pone.0063544-Davis2" ref-type="bibr">[26]</xref>, <xref rid="pone.0063544-Lamers2" ref-type="bibr">[28]</xref> despite the sensitivity of the cystathionine γ-lyase reaction to cellular PLP deficiency and resulting buildup of cystathionine in tissues and plasma <xref rid="pone.0063544-Lamers1" ref-type="bibr">[27]</xref>, <xref rid="pone.0063544-Park2" ref-type="bibr">[37]</xref>, <xref rid="pone.0063544-Davis3" ref-type="bibr">[38]</xref>. The PLP-dependent mitochondrial glycine cleavage system accounts for approximately 20 times more 5,10-methylenetetrahydrofolate production than needed for cellular methyl synthesis demands <xref rid="pone.0063544-Lamers5" ref-type="bibr">[59]</xref>. The increased glycine concentration frequently observed in marginal vitamin B-6 deficiency presumably reflects substrate accumulation due to reduced activity of the glycine cleavage system <xref rid="pone.0063544-Davis1" ref-type="bibr">[25]</xref>, <xref rid="pone.0063544-Lamers1" ref-type="bibr">[27]</xref>, <xref rid="pone.0063544-Nijhout1" ref-type="bibr">[58]</xref>. However, in vivo tracer kinetic results indicate no significant reduction in glycine cleavage system flux from vitamin B-6 restriction <xref rid="pone.0063544-Lamers1" ref-type="bibr">[27]</xref>.</p>
                <p>The spectral features reflecting substantial increases in asparagine and glutamine and the marked increase in the glutamine/glutamate ratio (<xref ref-type="table" rid="pone-0063544-t002">Table 2</xref>) observed here were unexpected. Neither glutamine synthetase, which catalyzes ATP-dependent condensation of glutamate and ammonia, nor asparagine synthetase, which catalyzes the ATP-dependent transfer of the terminal amide group of glutamine to aspartate, requires PLP, nor do the catabolic enzymes glutaminase and asparaginase. In view of the importance of inter-organ transport of glutamine and the regulatory role of glutaminases <xref rid="pone.0063544-Curthoys1" ref-type="bibr">[60]</xref>, <xref rid="pone.0063544-Brosnan1" ref-type="bibr">[61]</xref>, our findings suggest fundamental perturbations in the inter-organ trafficking of these amino acids may be responsible for the changes in their plasma concentrations associated with vitamin B-6 restriction. The unexpected increase in plasma proline suggests that it may be a secondary consequence of the altered glutamate and glutamine concentrations because proline synthesis occurs by way of pyrroline 5-carboxylate <xref rid="pone.0063544-Curthoys1" ref-type="bibr">[60]</xref>. It is likely that the changes in plasma myo-inositol and trimethylamine oxide were mainly attributable to differences in diet composition from the participants' pre-study diets, because their metabolism does not directly involve PLP-dependent processes.</p>
                <p>The activity and extent of coenzyme saturation of PLP-dependent aminotransferases has long been recognized and used diagnostically in assessing vitamin B-6 status <xref rid="pone.0063544-Sauberlich1" ref-type="bibr">[62]</xref>. However, the impact of vitamin B-6 insufficiency on the profile of tissue and plasma amino acids and, particularly, the sensitivity of such reactions in maintaining anaplerotic reactions remains unclear. Increases in plasma concentrations of pyruvate and 2-oxoglutarate may reflect reduced utilization of 2-ketoacids in aminotransferase reactions or in other phases of metabolism. The lack of a significant change in formate concentration is consistent with findings from an NMR study in rats, in which deficiency of vitamin B-12, but not B-6 deficiency, caused an increase in plasma and urinary formate <xref rid="pone.0063544-Lamarre1" ref-type="bibr">[63]</xref>. Changes in the profile of tryptophan catabolic products in the kynurenine pathway are associated with vitamin B-6 deficiency <xref rid="pone.0063544-Leklem1" ref-type="bibr">[10]</xref>, <xref rid="pone.0063544-Midttun1" ref-type="bibr">[64]</xref>, <xref rid="pone.0063544-Vilter1" ref-type="bibr">[65]</xref>. Targeted analysis has revealed such changes in tryptophan metabolites in the present study (reported separately).</p>
                <p>We have previously shown that vitamin B-6 deficiency is associated with markedly increased total glutathione concentration in rat liver in direct proportion to the severity of the deficiency <xref rid="pone.0063544-Lima1" ref-type="bibr">[66]</xref> and in altered glutathione synthesis in a subset of vitamin B-6 restricted healthy humans <xref rid="pone.0063544-Lamers6" ref-type="bibr">[67]</xref>. These responses may be due to oxidative stress associated with vitamin B-6 deficiency <xref rid="pone.0063544-Benderitter1" ref-type="bibr">[68]</xref>–<xref rid="pone.0063544-Cabrini1" ref-type="bibr">[70]</xref> independent of substrate availability, a hypothesis that has been supported by mathematical modeling <xref rid="pone.0063544-Nijhout1" ref-type="bibr">[58]</xref>. The role of such oxidative stress and its impact on the plasma metabolome during vitamin B-6 deficiency is presently unknown.</p>
              </sec>
            </sec>
            <sec id="s5">
              <title>Conclusions</title>
              <p>This study demonstrates that our vitamin B-6 restriction protocol induces fundamental changes in the plasma metabolite profile, strongly suggesting that marginal vitamin B-6 deficiency exerts far-reaching effects on human metabolism. These observations extend our understanding of the impact and interpretation of the marginal nutritional status and will aid in hypothesis development in the design of future research regarding the mechanistic relationship between low vitamin B-6 status and chronic disease.</p>
            </sec>
            <sec sec-type="supplementary-material" id="s6">
              <title>Supporting Information</title>
              <supplementary-material content-type="local-data" id="pone.0063544.s001">
                <label>Figure S1</label>
                <caption>
                  <p><bold>Representative <sup>1</sup>H-NMR spectra of unfiltered and filtered plasma from a single participant shown before and after vitamin B-6 restriction, with signals from EDTA designated.</bold> Small arrows designate visually apparent differences in certain spectral features of these spectra.</p>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0063544.s001.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0063544.s002">
                <label>Table S1</label>
                <caption>
                  <p>
                    <bold>Baseline characteristics of 23 healthy men and women participating in the study.</bold>
                  </p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0063544.s002.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pone.0063544.s003">
                <label>Table S2</label>
                <caption>
                  <p>
                    <bold>Concentration of individual and total acylcarnitines in plasma determined by tandem mass spectrometry before and after vitamin B-6 restriction.</bold>
                  </p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0063544.s003.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>The excellent technical assistance of Maria Ralat is gratefully acknowledged.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0063544-Morris1">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>MS</given-names></name>, <name><surname>Picciano</surname><given-names>MF</given-names></name>, <name><surname>Jacques</surname><given-names>PF</given-names></name>, <name><surname>Selhub</surname><given-names>J</given-names></name> (<year>2008</year>) <article-title>Plasma pyridoxal 5′-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003–2004</article-title>. <source>Am J Clin Nutr</source>
<volume>87</volume>: <fpage>1446</fpage>–<lpage>1454</lpage>.<pub-id pub-id-type="pmid">18469270</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Fulgoni1">
                <label>2</label>
                <mixed-citation publication-type="journal"><collab>Fulgoni VL 3rd, Keast DR, Bailey RL, Dwyer J</collab> (<year>2011</year>) <article-title>Foods, fortificants, and supplements: Where do Americans get their nutrients?</article-title>
<source>J Nutr</source>
<volume>141</volume>: <fpage>1847</fpage>–<lpage>1854</lpage>.<pub-id pub-id-type="pmid">21865568</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Institute1">
                <label>3</label>
                <mixed-citation publication-type="other">Institute of Medicine, Food and Nutrition Board (1998) Dietary Reference Intakes: Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press.</mixed-citation>
              </ref>
              <ref id="pone.0063544-Centers1">
                <label>4</label>
                <mixed-citation publication-type="other">Centers for Disease Control and Prevention (2012) Second National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population 2012. Atlanta (GA): National Center for Environmental Health. 1–484 p.</mixed-citation>
              </ref>
              <ref id="pone.0063544-Lotto1">
                <label>5</label>
                <mixed-citation publication-type="other">Lotto V, Choi SW, Friso S (2011) Vitamin B6: a challenging link between nutrition and inflammation in CVD. Br J Nutr: 1–13.</mixed-citation>
              </ref>
              <ref id="pone.0063544-Morris2">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>MS</given-names></name>, <name><surname>Sakakeeny</surname><given-names>L</given-names></name>, <name><surname>Jacques</surname><given-names>PF</given-names></name>, <name><surname>Picciano</surname><given-names>MF</given-names></name>, <name><surname>Selhub</surname><given-names>J</given-names></name> (<year>2010</year>) <article-title>Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status</article-title>. <source>J Nutr</source>
<volume>140</volume>: <fpage>103</fpage>–<lpage>110</lpage>.<pub-id pub-id-type="pmid">19906811</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Ubbink1">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Ubbink</surname><given-names>JB</given-names></name>, <name><surname>van der Merwe</surname><given-names>A</given-names></name>, <name><surname>Delport</surname><given-names>R</given-names></name>, <name><surname>Allen</surname><given-names>RH</given-names></name>, <name><surname>Stabler</surname><given-names>SP</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>The effect of a subnormal vitamin B-6 status on homocysteine metabolism</article-title>. <source>J Clin Invest</source>
<volume>98</volume>: <fpage>177</fpage>–<lpage>184</lpage>.<pub-id pub-id-type="pmid">8690790</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Lussana1">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Lussana</surname><given-names>F</given-names></name>, <name><surname>Zighetti</surname><given-names>ML</given-names></name>, <name><surname>Bucciarelli</surname><given-names>P</given-names></name>, <name><surname>Cugno</surname><given-names>M</given-names></name>, <name><surname>Cattaneo</surname><given-names>M</given-names></name> (<year>2003</year>) <article-title>Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users</article-title>. <source>Thromb Res</source>
<volume>112</volume>: <fpage>37</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">15013271</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-daSilva1">
                <label>9</label>
                <mixed-citation publication-type="other">da Silva VR, Russell KA, Gregory JF (2012) Vitamin B-6. In: Erdman JW, McDonald IA, Zeisel SH, editors. Present Knowledge in Nutrition, 10th Edition. 307–320.</mixed-citation>
              </ref>
              <ref id="pone.0063544-Leklem1">
                <label>10</label>
                <mixed-citation publication-type="other">Leklem J (1998) Vitamin B6. In: Shils ME OJ, Shihe M, Ross AC,, editor. Modern Nutrition in Health and Disease, Ninth Edition. Blatimore, MD: Williams &amp; Wilkins. 1413–1421.</mixed-citation>
              </ref>
              <ref id="pone.0063544-Mackey1">
                <label>11</label>
                <mixed-citation publication-type="other">Mackey A, Davis S, Gregory J (2005) Vitamin B6. In: Shils M, editor. Modern Nutrition in Health and Disease, 9th Ed. Baltimore, MD: Wilkins and Wilkins. 452–461.</mixed-citation>
              </ref>
              <ref id="pone.0063544-Rimm1">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Rimm</surname><given-names>EB</given-names></name>, <name><surname>Willett</surname><given-names>WC</given-names></name>, <name><surname>Hu</surname><given-names>FB</given-names></name>, <name><surname>Sampson</surname><given-names>L</given-names></name>, <name><surname>Colditz</surname><given-names>GA</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women</article-title>. <source>JAMA</source>
<volume>279</volume>: <fpage>359</fpage>–<lpage>364</lpage>.<pub-id pub-id-type="pmid">9459468</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Robinson1">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>K</given-names></name>, <name><surname>Arheart</surname><given-names>K</given-names></name>, <name><surname>Refsum</surname><given-names>H</given-names></name>, <name><surname>Brattstrom</surname><given-names>L</given-names></name>, <name><surname>Boers</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group</article-title>. <source>Circulation</source>
<volume>97</volume>: <fpage>437</fpage>–<lpage>443</lpage>.<pub-id pub-id-type="pmid">9490237</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Robinson2">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>K</given-names></name>, <name><surname>Gupta</surname><given-names>A</given-names></name>, <name><surname>Dennis</surname><given-names>V</given-names></name>, <name><surname>Arheart</surname><given-names>K</given-names></name>, <name><surname>Chaudhary</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations</article-title>. <source>Circulation</source>
<volume>94</volume>: <fpage>2743</fpage>–<lpage>2748</lpage>.<pub-id pub-id-type="pmid">8941098</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Dalery1">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Dalery</surname><given-names>K</given-names></name>, <name><surname>Lussier-Cacan</surname><given-names>S</given-names></name>, <name><surname>Selhub</surname><given-names>J</given-names></name>, <name><surname>Davignon</surname><given-names>J</given-names></name>, <name><surname>Latour</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>1995</year>) <article-title>Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate</article-title>. <source>Am J Cardiol</source>
<volume>75</volume>: <fpage>1107</fpage>–<lpage>1111</lpage>.<pub-id pub-id-type="pmid">7762494</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Verhoef1">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Verhoef</surname><given-names>P</given-names></name>, <name><surname>Stampfer</surname><given-names>MJ</given-names></name>, <name><surname>Buring</surname><given-names>JE</given-names></name>, <name><surname>Gaziano</surname><given-names>JM</given-names></name>, <name><surname>Allen</surname><given-names>RH</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate</article-title>. <source>Am J Epidemiol</source>
<volume>143</volume>: <fpage>845</fpage>–<lpage>859</lpage>.<pub-id pub-id-type="pmid">8610698</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Miller1">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>JW</given-names></name>, <name><surname>Green</surname><given-names>R</given-names></name>, <name><surname>Mungas</surname><given-names>DM</given-names></name>, <name><surname>Reed</surname><given-names>BR</given-names></name>, <name><surname>Jagust</surname><given-names>WJ</given-names></name> (<year>2002</year>) <article-title>Homocysteine, vitamin B6, and vascular disease in AD patients</article-title>. <source>Neurology</source>
<volume>58</volume>: <fpage>1471</fpage>–<lpage>1475</lpage>.<pub-id pub-id-type="pmid">12034781</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Hron1">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Hron</surname><given-names>G</given-names></name>, <name><surname>Lombardi</surname><given-names>R</given-names></name>, <name><surname>Eichinger</surname><given-names>S</given-names></name>, <name><surname>Lecchi</surname><given-names>A</given-names></name>, <name><surname>Kyrle</surname><given-names>PA</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Low vitamin B6 levels and the risk of recurrent venous thromboembolism</article-title>. <source>Haematologica</source>
<volume>92</volume>: <fpage>1250</fpage>–<lpage>1253</lpage>.<pub-id pub-id-type="pmid">17666362</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Cattaneo1">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Cattaneo</surname><given-names>M</given-names></name>, <name><surname>Lombardi</surname><given-names>R</given-names></name>, <name><surname>Lecchi</surname><given-names>A</given-names></name>, <name><surname>Bucciarelli</surname><given-names>P</given-names></name>, <name><surname>Mannucci</surname><given-names>PM</given-names></name> (<year>2001</year>) <article-title>Low plasma levels of vitamin B(6) are independently associated with a heightened risk of deep-vein thrombosis</article-title>. <source>Circulation</source>
<volume>104</volume>: <fpage>2442</fpage>–<lpage>2446</lpage>.<pub-id pub-id-type="pmid">11705822</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Vanuzzo1">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Vanuzzo</surname><given-names>D</given-names></name>, <name><surname>Pilotto</surname><given-names>L</given-names></name>, <name><surname>Lombardi</surname><given-names>R</given-names></name>, <name><surname>Lazzerini</surname><given-names>G</given-names></name>, <name><surname>Carluccio</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects</article-title>. <source>Eur Heart J</source>
<volume>28</volume>: <fpage>484</fpage>–<lpage>491</lpage>.<pub-id pub-id-type="pmid">17267459</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Kelly1">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Kelly</surname><given-names>PJ</given-names></name>, <name><surname>Shih</surname><given-names>VE</given-names></name>, <name><surname>Kistler</surname><given-names>JP</given-names></name>, <name><surname>Barron</surname><given-names>M</given-names></name>, <name><surname>Lee</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Low vitamin B6 but not homocyst(e)ine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification</article-title>. <source>Stroke</source>
<volume>34</volume>: <fpage>e51</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">12738890</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Larsson1">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Larsson</surname><given-names>SC</given-names></name>, <name><surname>Orsini</surname><given-names>N</given-names></name>, <name><surname>Wolk</surname><given-names>A</given-names></name> (<year>2010</year>) <article-title>Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies</article-title>. <source>JAMA</source>
<volume>303</volume>: <fpage>1077</fpage>–<lpage>1083</lpage>.<pub-id pub-id-type="pmid">20233826</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Johansson1">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Johansson</surname><given-names>M</given-names></name>, <name><surname>Relton</surname><given-names>C</given-names></name>, <name><surname>Ueland</surname><given-names>PM</given-names></name>, <name><surname>Vollset</surname><given-names>SE</given-names></name>, <name><surname>Midttun</surname><given-names>O</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Serum B vitamin levels and risk of lung cancer</article-title>. <source>JAMA</source>
<volume>303</volume>: <fpage>2377</fpage>–<lpage>2385</lpage>.<pub-id pub-id-type="pmid">20551408</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Cuskelly1">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Cuskelly</surname><given-names>G</given-names></name>, <name><surname>Stacpoole</surname><given-names>P</given-names></name>, <name><surname>Williamson</surname><given-names>J</given-names></name>, <name><surname>Baumgartner</surname><given-names>T</given-names></name>, <name><surname>Gregory</surname><given-names>JF</given-names></name> (<year>2001</year>) <article-title>Deficiencies of folate and vitamin B(6) exert distinct effects on homocysteine, serine, and methionine kinetics</article-title>. <source>Am J Physiol Endocrinol Metab</source>
<volume>281</volume>: <fpage>E1182</fpage>–<lpage>1190</lpage>.<pub-id pub-id-type="pmid">11701432</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Davis1">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>SR</given-names></name>, <name><surname>Scheer</surname><given-names>JB</given-names></name>, <name><surname>Quinlivan</surname><given-names>EP</given-names></name>, <name><surname>Coats</surname><given-names>BS</given-names></name>, <name><surname>Stacpoole</surname><given-names>PW</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Dietary vitamin B-6 restriction does not alter rates of homocysteine remethylation or synthesis in healthy young women and men</article-title>. <source>Am J Clin Nutr</source>
<volume>81</volume>: <fpage>648</fpage>–<lpage>655</lpage>.<pub-id pub-id-type="pmid">15755835</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Davis2">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>S</given-names></name>, <name><surname>Quinlivan</surname><given-names>E</given-names></name>, <name><surname>Stacpoole</surname><given-names>P</given-names></name>, <name><surname>Gregory</surname><given-names>JF</given-names></name> (<year>2006</year>) <article-title>Plasma glutathione and cystathionine concentrations are elevated but cysteine flux is unchanged by dietary vitamin B-6 restriction in young men and women</article-title>. <source>J Nutr</source>
<volume>136</volume>: <fpage>373</fpage>–<lpage>378</lpage>.<pub-id pub-id-type="pmid">16424114</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Lamers1">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Lamers</surname><given-names>Y</given-names></name>, <name><surname>Williamson</surname><given-names>J</given-names></name>, <name><surname>Ralat</surname><given-names>M</given-names></name>, <name><surname>Quinlivan</surname><given-names>EP</given-names></name>, <name><surname>Gilbert</surname><given-names>LR</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Moderate dietary vitamin B-6 restriction raises plasma glycine and cystathionine concentrations while minimally affecting the rates of glycine turnover and glycine cleavage in healthy men and women</article-title>. <source>J Nutr</source>
<volume>139</volume>: <fpage>452</fpage>–<lpage>460</lpage>.<pub-id pub-id-type="pmid">19158217</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Lamers2">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Lamers</surname><given-names>Y</given-names></name>, <name><surname>Coats</surname><given-names>B</given-names></name>, <name><surname>Ralat</surname><given-names>M</given-names></name>, <name><surname>Quinlivan</surname><given-names>EP</given-names></name>, <name><surname>Stacpoole</surname><given-names>PW</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Moderate vitamin B-6 restriction does not alter postprandial methionine cycle rates of remethylation, transmethylation, and total transsulfuration but increases the fractional synthesis rate of cystathionine in healthy young men and women</article-title>. <source>J Nutr</source>
<volume>141</volume>: <fpage>835</fpage>–<lpage>842</lpage>.<pub-id pub-id-type="pmid">21430249</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Zhao1">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>M</given-names></name>, <name><surname>Lamers</surname><given-names>Y</given-names></name>, <name><surname>Ralat</surname><given-names>MA</given-names></name>, <name><surname>Coats</surname><given-names>BS</given-names></name>, <name><surname>Chi</surname><given-names>YY</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Marginal vitamin B-6 deficiency decreases plasma (n-3) and (n-6) PUFA concentrations in healthy men and women</article-title>. <source>J Nutr</source>
<volume>142</volume>: <fpage>1791</fpage>–<lpage>1797</lpage>.<pub-id pub-id-type="pmid">22955512</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-German1">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>German</surname><given-names>JB</given-names></name>, <name><surname>Bauman</surname><given-names>DE</given-names></name>, <name><surname>Burrin</surname><given-names>DG</given-names></name>, <name><surname>Failla</surname><given-names>ML</given-names></name>, <name><surname>Freake</surname><given-names>HC</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Metabolomics in the opening decade of the 21st century: building the roads to individualized health</article-title>. <source>J Nutr</source>
<volume>134</volume>: <fpage>2729</fpage>–<lpage>2732</lpage>.<pub-id pub-id-type="pmid">15465774</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Zeisel1">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Zeisel</surname><given-names>SH</given-names></name>, <name><surname>Freake</surname><given-names>HC</given-names></name>, <name><surname>Bauman</surname><given-names>DE</given-names></name>, <name><surname>Bier</surname><given-names>DM</given-names></name>, <name><surname>Burrin</surname><given-names>DG</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>The nutritional phenotype in the age of metabolomics</article-title>. <source>J Nutr</source>
<volume>135</volume>: <fpage>1613</fpage>–<lpage>1616</lpage>.<pub-id pub-id-type="pmid">15987837</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Park1">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>Y</given-names></name>, <name><surname>Le</surname><given-names>NA</given-names></name>, <name><surname>Yu</surname><given-names>T</given-names></name>, <name><surname>Strobel</surname><given-names>F</given-names></name>, <name><surname>Gletsu-Miller</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>A sulfur amino acid-free meal increases plasma lipids in humans</article-title>. <source>J Nutr</source>
<volume>141</volume>: <fpage>1424</fpage>–<lpage>1431</lpage>.<pub-id pub-id-type="pmid">21677075</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Gu1">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Gu</surname><given-names>H</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Pan</surname><given-names>Z</given-names></name>, <name><surname>Jackson</surname><given-names>AU</given-names></name>, <name><surname>Talaty</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Monitoring diet effects via biofluids and their implications for metabolomics studies</article-title>. <source>Anal Chem</source>
<volume>79</volume>: <fpage>89</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">17194125</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Duggan1">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Duggan</surname><given-names>GE</given-names></name>, <name><surname>Joan Miller</surname><given-names>B</given-names></name>, <name><surname>Jirik</surname><given-names>FR</given-names></name>, <name><surname>Vogel</surname><given-names>HJ</given-names></name> (<year>2011</year>) <article-title>Metabolic profiling of vitamin C deficiency in Gulo−/− mice using proton NMR spectroscopy</article-title>. <source>J Biomol NMR</source>
<volume>49</volume>: <fpage>165</fpage>–<lpage>173</lpage>.<pub-id pub-id-type="pmid">21360155</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Ubbink2">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Ubbink</surname><given-names>JB</given-names></name>, <name><surname>Serfontein</surname><given-names>WJ</given-names></name>, <name><surname>de Villiers</surname><given-names>LS</given-names></name> (<year>1985</year>) <article-title>Stability of pyridoxal-5-phosphate semicarbazone: applications in plasma vitamin B6 analysis and population surveys of vitamin B6 nutritional status</article-title>. <source>J Chromatogr</source>
<volume>342</volume>: <fpage>277</fpage>–<lpage>284</lpage>.<pub-id pub-id-type="pmid">4055950</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Pfeiffer1">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Pfeiffer</surname><given-names>CM</given-names></name>, <name><surname>Huff</surname><given-names>DL</given-names></name>, <name><surname>Gunter</surname><given-names>EW</given-names></name> (<year>1999</year>) <article-title>Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting</article-title>. <source>Clin Chem</source>
<volume>45</volume>: <fpage>290</fpage>–<lpage>292</lpage>.<pub-id pub-id-type="pmid">9931056</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Park2">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>YK</given-names></name>, <name><surname>Linkswiler</surname><given-names>H</given-names></name> (<year>1970</year>) <article-title>Effect of vitamin B6 depletion in adult man on the excretion of cystathionine and other methionine metabolites</article-title>. <source>J Nutr</source>
<volume>100</volume>: <fpage>110</fpage>–<lpage>116</lpage>.<pub-id pub-id-type="pmid">5412124</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Davis3">
                <label>38</label>
                <mixed-citation publication-type="journal"><collab>Davis SR, Quinlivan EP, Stacpoole PW, Gregory JF 3rd</collab> (<year>2006</year>) <article-title>Plasma glutathione and cystathionine concentrations are elevated but cysteine flux is unchanged by dietary vitamin B-6 restriction in young men and women</article-title>. <source>J Nutr</source>
<volume>136</volume>: <fpage>373</fpage>–<lpage>378</lpage>.<pub-id pub-id-type="pmid">16424114</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Ferrara1">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Ferrara</surname><given-names>CT</given-names></name>, <name><surname>Wang</surname><given-names>P</given-names></name>, <name><surname>Neto</surname><given-names>EC</given-names></name>, <name><surname>Stevens</surname><given-names>RD</given-names></name>, <name><surname>Bain</surname><given-names>JR</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling</article-title>. <source>PLoS Genet</source>
<volume>4</volume>: <fpage>e1000034</fpage>.<pub-id pub-id-type="pmid">18369453</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Park3">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>Y</given-names></name>, <name><surname>Kim</surname><given-names>SB</given-names></name>, <name><surname>Wang</surname><given-names>B</given-names></name>, <name><surname>Blanco</surname><given-names>RA</given-names></name>, <name><surname>Le</surname><given-names>NA</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Individual variation in macronutrient regulation measured by proton magnetic resonance spectroscopy of human plasma</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source>
<volume>297</volume>: <fpage>R202</fpage>–<lpage>209</lpage>.<pub-id pub-id-type="pmid">19458279</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Forshed1">
                <label>41</label>
                <mixed-citation publication-type="other">Forshed J, Schuppe-Koistinen I, Jacobsson SP (2003) Peak alignment of NMR signals by means of a genetic algorithm.</mixed-citation>
              </ref>
              <ref id="pone.0063544-Lee1">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>GC</given-names></name>, <name><surname>Woodruff</surname><given-names>DL</given-names></name> (<year>2004</year>) <article-title>Beam search for peak alignment of NMR signals</article-title>. <source>Analytica Chimica Acta</source>
<volume>513</volume>: <fpage>413</fpage>–<lpage>416</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0063544-Nicholson1">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Nicholson</surname><given-names>JK</given-names></name>, <name><surname>Foxall</surname><given-names>PJ</given-names></name>, <name><surname>Spraul</surname><given-names>M</given-names></name>, <name><surname>Farrant</surname><given-names>RD</given-names></name>, <name><surname>Lindon</surname><given-names>JC</given-names></name> (<year>1995</year>) <article-title>750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma</article-title>. <source>Anal Chem</source>
<volume>67</volume>: <fpage>793</fpage>–<lpage>811</lpage>.<pub-id pub-id-type="pmid">7762816</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Barton1">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Barton</surname><given-names>RH</given-names></name>, <name><surname>Waterman</surname><given-names>D</given-names></name>, <name><surname>Bonner</surname><given-names>FW</given-names></name>, <name><surname>Holmes</surname><given-names>E</given-names></name>, <name><surname>Clarke</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies</article-title>. <source>Mol Biosyst</source>
<volume>6</volume>: <fpage>215</fpage>–<lpage>224</lpage>.<pub-id pub-id-type="pmid">20024083</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Weljie1">
                <label>45</label>
                <mixed-citation publication-type="journal"><name><surname>Weljie</surname><given-names>AM</given-names></name>, <name><surname>Newton</surname><given-names>J</given-names></name>, <name><surname>Mercier</surname><given-names>P</given-names></name>, <name><surname>Carlson</surname><given-names>E</given-names></name>, <name><surname>Slupsky</surname><given-names>CM</given-names></name> (<year>2006</year>) <article-title>Targeted profiling: quantitative analysis of 1H NMR metabolomics data</article-title>. <source>Anal Chem</source>
<volume>78</volume>: <fpage>4430</fpage>–<lpage>4442</lpage>.<pub-id pub-id-type="pmid">16808451</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Weljie2">
                <label>46</label>
                <mixed-citation publication-type="journal"><name><surname>Weljie</surname><given-names>AM</given-names></name>, <name><surname>Newton</surname><given-names>J</given-names></name>, <name><surname>Jirik</surname><given-names>FR</given-names></name>, <name><surname>Vogel</surname><given-names>HJ</given-names></name> (<year>2008</year>) <article-title>Evaluating low-intensity unknown signals in quantitative proton NMR mixture analysis</article-title>. <source>Anal Chem</source>
<volume>80</volume>: <fpage>8956</fpage>–<lpage>8965</lpage>.<pub-id pub-id-type="pmid">19551928</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Walsh1">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>Walsh</surname><given-names>MC</given-names></name>, <name><surname>Brennan</surname><given-names>L</given-names></name>, <name><surname>Pujos-Guillot</surname><given-names>E</given-names></name>, <name><surname>Sebedio</surname><given-names>JL</given-names></name>, <name><surname>Scalbert</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Influence of acute phytochemical intake on human urinary metabolomic profiles</article-title>. <source>Am J Clin Nutr</source>
<volume>86</volume>: <fpage>1687</fpage>–<lpage>1693</lpage>.<pub-id pub-id-type="pmid">18065587</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Wiklund1">
                <label>48</label>
                <mixed-citation publication-type="journal"><name><surname>Wiklund</surname><given-names>S</given-names></name>, <name><surname>Johansson</surname><given-names>E</given-names></name>, <name><surname>Sjostrom</surname><given-names>L</given-names></name>, <name><surname>Mellerowicz</surname><given-names>EJ</given-names></name>, <name><surname>Edlund</surname><given-names>U</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Visualization of GC/TOF-MS-based metabolomics data for identification of</article-title>. <source>Anal Chem</source>
<volume>80</volume>: <fpage>115</fpage>–<lpage>122</lpage>.<pub-id pub-id-type="pmid">18027910</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Chi1">
                <label>49</label>
                <mixed-citation publication-type="journal"><name><surname>Chi</surname><given-names>YY</given-names></name>, <name><surname>Gribbin</surname><given-names>M</given-names></name>, <name><surname>Lamers</surname><given-names>Y</given-names></name>, <name><surname>Gregory</surname><given-names>JF</given-names></name>, <name><surname>Muller</surname><given-names>KE</given-names></name> (<year>2012</year>) <article-title>Global hypothesis testing for high-dimensional repeated measures outcomes</article-title>. <source>Stat Med</source>
<volume>31</volume>: <fpage>724</fpage>–<lpage>742</lpage>.<pub-id pub-id-type="pmid">22161561</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Storey1">
                <label>50</label>
                <mixed-citation publication-type="journal"><name><surname>Storey</surname><given-names>JD</given-names></name> (<year>2012</year>) <article-title>A direct approach to false discovery rates</article-title>. <source>Journal of the Royal Statistical Society: Series B (Statistical Methodology)</source>
<volume>64</volume>: <fpage>479</fpage>–<lpage>498</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0063544-Lamers3">
                <label>51</label>
                <mixed-citation publication-type="journal"><name><surname>Lamers</surname><given-names>Y</given-names></name>, <name><surname>Williamson</surname><given-names>J</given-names></name>, <name><surname>Gilbert</surname><given-names>L</given-names></name>, <name><surname>Stacpoole</surname><given-names>P</given-names></name>, <name><surname>Gregory</surname><given-names>JF</given-names></name> (<year>2007</year>) <article-title>Glycine turnover and decarboxylation rate quantified in healthy men and women using primed, constant infusions of [1,2-(13)C2]glycine and [(2)H3]leucine</article-title>. <source>J Nutr</source>
<volume>137</volume>: <fpage>2647</fpage>–<lpage>2652</lpage>.<pub-id pub-id-type="pmid">18029478</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Lamers4">
                <label>52</label>
                <mixed-citation publication-type="journal"><name><surname>Lamers</surname><given-names>Y</given-names></name>, <name><surname>Coats</surname><given-names>B</given-names></name>, <name><surname>Ralat</surname><given-names>M</given-names></name>, <name><surname>Quinlivan</surname><given-names>EP</given-names></name>, <name><surname>Stacpoole</surname><given-names>PW</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Moderate vitamin B-6 restriction does not alter postprandial methionine cycle rates of remethylation, transmethylation, and total transsulfuration but increases the fractional synthesis rate of cystathionine in healthy young men and women</article-title>. <source>J Nutr</source>
<volume>141</volume>: <fpage>835</fpage>–<lpage>842</lpage>.<pub-id pub-id-type="pmid">21430249</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Solanky1">
                <label>53</label>
                <mixed-citation publication-type="journal"><name><surname>Solanky</surname><given-names>KS</given-names></name>, <name><surname>Bailey</surname><given-names>NJ</given-names></name>, <name><surname>Beckwith-Hall</surname><given-names>BM</given-names></name>, <name><surname>Davis</surname><given-names>A</given-names></name>, <name><surname>Bingham</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Application of biofluid 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile</article-title>. <source>Anal Biochem</source>
<volume>323</volume>: <fpage>197</fpage>–<lpage>204</lpage>.<pub-id pub-id-type="pmid">14656525</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Westerhuis1">
                <label>54</label>
                <mixed-citation publication-type="journal"><name><surname>Westerhuis</surname><given-names>JA</given-names></name>, <name><surname>van Velzen</surname><given-names>EJ</given-names></name>, <name><surname>Hoefsloot</surname><given-names>HC</given-names></name>, <name><surname>Smilde</surname><given-names>AK</given-names></name> (<year>2010</year>) <article-title>Multivariate paired data analysis: multilevel PLSDA versus OPLSDA</article-title>. <source>Metabolomics</source>
<volume>6</volume>: <fpage>119</fpage>–<lpage>128</lpage>.<pub-id pub-id-type="pmid">20339442</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Aristoteli1">
                <label>55</label>
                <mixed-citation publication-type="journal"><name><surname>Aristoteli</surname><given-names>LP</given-names></name>, <name><surname>Molloy</surname><given-names>MP</given-names></name>, <name><surname>Baker</surname><given-names>MS</given-names></name> (<year>2007</year>) <article-title>Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery</article-title>. <source>J Proteome Res</source>
<volume>6</volume>: <fpage>571</fpage>–<lpage>581</lpage>.<pub-id pub-id-type="pmid">17269714</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Tredwell1">
                <label>56</label>
                <mixed-citation publication-type="journal"><name><surname>Tredwell</surname><given-names>GD</given-names></name>, <name><surname>Behrends</surname><given-names>V</given-names></name>, <name><surname>Geier</surname><given-names>FM</given-names></name>, <name><surname>Liebeke</surname><given-names>M</given-names></name>, <name><surname>Bundy</surname><given-names>JG</given-names></name> (<year>2011</year>) <article-title>Between-person comparison of metabolite fitting for NMR-based quantitative metabolomics</article-title>. <source>Anal Chem</source>
<volume>83</volume>: <fpage>8683</fpage>–<lpage>8687</lpage>.<pub-id pub-id-type="pmid">21988367</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Scheer1">
                <label>57</label>
                <mixed-citation publication-type="journal"><name><surname>Scheer</surname><given-names>J</given-names></name>, <name><surname>Mackey</surname><given-names>A</given-names></name>, <name><surname>Gregory</surname><given-names>JF</given-names></name> (<year>2005</year>) <article-title>Activities of hepatic cytosolic and mitochondrial forms of serine hydroxymethyltransferase and hepatic glycine concentration are affected by vitamin B-6 intake in rats</article-title>. <source>J Nutr</source>
<volume>135</volume>: <fpage>233</fpage>–<lpage>238</lpage>.<pub-id pub-id-type="pmid">15671219</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Nijhout1">
                <label>58</label>
                <mixed-citation publication-type="journal"><name><surname>Nijhout</surname><given-names>H</given-names></name>, <name><surname>Gregory</surname><given-names>J</given-names></name>, <name><surname>Fitzpatrick</surname><given-names>C</given-names></name>, <name><surname>Cho</surname><given-names>E</given-names></name>, <name><surname>Lamers</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>A mathematical model gives insights into the effects of vitamin B-6 deficiency on 1-carbon and glutathione metabolism</article-title>. <source>J Nutr</source>
<volume>139</volume>: <fpage>784</fpage>–<lpage>791</lpage>.<pub-id pub-id-type="pmid">19244383</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Lamers5">
                <label>59</label>
                <mixed-citation publication-type="journal"><name><surname>Lamers</surname><given-names>Y</given-names></name>, <name><surname>Williamson</surname><given-names>J</given-names></name>, <name><surname>Theriaque</surname><given-names>D</given-names></name>, <name><surname>Shuster</surname><given-names>J</given-names></name>, <name><surname>Gilbert</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Production of 1-carbon units from glycine is extensive in healthy men and women</article-title>. <source>J Nutr</source>
<volume>139</volume>: <fpage>666</fpage>–<lpage>671</lpage>.<pub-id pub-id-type="pmid">19244382</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Curthoys1">
                <label>60</label>
                <mixed-citation publication-type="journal"><name><surname>Curthoys</surname><given-names>NP</given-names></name>, <name><surname>Watford</surname><given-names>M</given-names></name> (<year>1995</year>) <article-title>Regulation of glutaminase activity and glutamine metabolism</article-title>. <source>Annu Rev Nutr</source>
<volume>15</volume>: <fpage>133</fpage>–<lpage>159</lpage>.<pub-id pub-id-type="pmid">8527215</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Brosnan1">
                <label>61</label>
                <mixed-citation publication-type="journal"><name><surname>Brosnan</surname><given-names>JT</given-names></name> (<year>2003</year>) <article-title>Interorgan amino acid transport and its regulation</article-title>. <source>J Nutr</source>
<volume>133</volume>: <fpage>2068S</fpage>–<lpage>2072S</lpage>.<pub-id pub-id-type="pmid">12771367</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Sauberlich1">
                <label>62</label>
                <mixed-citation publication-type="journal"><name><surname>Sauberlich</surname><given-names>HE</given-names></name>, <name><surname>Canham</surname><given-names>JE</given-names></name>, <name><surname>Baker</surname><given-names>EM</given-names></name>, <name><surname>Raica</surname><given-names>N</given-names><suffix>Jr</suffix></name>, <name><surname>Herman</surname><given-names>YF</given-names></name> (<year>1972</year>) <article-title>Biochemical assessment of the nutritional status of vitamin B 6 in the human</article-title>. <source>Am J Clin Nutr</source>
<volume>25</volume>: <fpage>629</fpage>–<lpage>642</lpage>.<pub-id pub-id-type="pmid">4556000</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Lamarre1">
                <label>63</label>
                <mixed-citation publication-type="journal"><name><surname>Lamarre</surname><given-names>SG</given-names></name>, <name><surname>Molloy</surname><given-names>AM</given-names></name>, <name><surname>Reinke</surname><given-names>SN</given-names></name>, <name><surname>Sykes</surname><given-names>BD</given-names></name>, <name><surname>Brosnan</surname><given-names>ME</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Formate can differentiate between hyperhomocysteinemia due to impaired remethylation and impaired transsulfuration</article-title>. <source>Am J Physiol Endocrinol Metab</source>
<volume>302</volume>: <fpage>E61</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">21934042</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Midttun1">
                <label>64</label>
                <mixed-citation publication-type="journal"><name><surname>Midttun</surname><given-names>O</given-names></name>, <name><surname>Ulvik</surname><given-names>A</given-names></name>, <name><surname>Ringdal Pedersen</surname><given-names>E</given-names></name>, <name><surname>Ebbing</surname><given-names>M</given-names></name>, <name><surname>Bleie</surname><given-names>O</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation</article-title>. <source>J Nutr</source>
<volume>141</volume>: <fpage>611</fpage>–<lpage>617</lpage>.<pub-id pub-id-type="pmid">21310866</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Vilter1">
                <label>65</label>
                <mixed-citation publication-type="journal"><name><surname>Vilter</surname><given-names>RW</given-names></name>, <name><surname>Mueller</surname><given-names>JF</given-names></name>, <name><surname>Glazer</surname><given-names>HS</given-names></name>, <name><surname>Jarrold</surname><given-names>T</given-names></name>, <name><surname>Abraham</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>1953</year>) <article-title>The effect of vitamin B6 deficiency induced by desoxypyridoxine in human beings</article-title>. <source>J Lab Clin Med</source>
<volume>42</volume>: <fpage>335</fpage>–<lpage>357</lpage>.<pub-id pub-id-type="pmid">13085024</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Lima1">
                <label>66</label>
                <mixed-citation publication-type="journal"><name><surname>Lima</surname><given-names>CP</given-names></name>, <name><surname>Davis</surname><given-names>SR</given-names></name>, <name><surname>Mackey</surname><given-names>AD</given-names></name>, <name><surname>Scheer</surname><given-names>JB</given-names></name>, <name><surname>Williamson</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Vitamin B-6 deficiency suppresses the hepatic transsulfuration pathway but increases glutathione concentration in rats fed AIN-76A or AIN-93G diets</article-title>. <source>J Nutr</source>
<volume>136</volume>: <fpage>2141</fpage>–<lpage>2147</lpage>.<pub-id pub-id-type="pmid">16857832</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Lamers6">
                <label>67</label>
                <mixed-citation publication-type="journal"><name><surname>Lamers</surname><given-names>Y</given-names></name>, <name><surname>O'Rourke</surname><given-names>B</given-names></name>, <name><surname>Gilbert</surname><given-names>L</given-names></name>, <name><surname>Keeling</surname><given-names>C</given-names></name>, <name><surname>Matthews</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Vitamin B-6 restriction tends to reduce the red blood cell glutathione synthesis rate without affecting red blood cell or plasma glutathione concentrations in healthy men and women</article-title>. <source>Am J Clin Nutr</source>
<volume>90</volume>: <fpage>336</fpage>–<lpage>343</lpage>.<pub-id pub-id-type="pmid">19515736</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Benderitter1">
                <label>68</label>
                <mixed-citation publication-type="journal"><name><surname>Benderitter</surname><given-names>M</given-names></name>, <name><surname>Hadj-Saad</surname><given-names>F</given-names></name>, <name><surname>Lhuissier</surname><given-names>M</given-names></name>, <name><surname>Maupoil</surname><given-names>V</given-names></name>, <name><surname>Guilland</surname><given-names>JC</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>Effects of exhaustive exercise and vitamin B6 deficiency on free radical oxidative process in male trained rats</article-title>. <source>Free Radic Biol Med</source>
<volume>21</volume>: <fpage>541</fpage>–<lpage>549</lpage>.<pub-id pub-id-type="pmid">8886806</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Taysi1">
                <label>69</label>
                <mixed-citation publication-type="journal"><name><surname>Taysi</surname><given-names>S</given-names></name> (<year>2005</year>) <article-title>Oxidant/antioxidant status in liver tissue of vitamin B6 deficient rats</article-title>. <source>Clin Nutr</source>
<volume>24</volume>: <fpage>385</fpage>–<lpage>389</lpage>.<pub-id pub-id-type="pmid">15896424</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0063544-Cabrini1">
                <label>70</label>
                <mixed-citation publication-type="journal"><name><surname>Cabrini</surname><given-names>L</given-names></name>, <name><surname>Bergami</surname><given-names>R</given-names></name>, <name><surname>Fiorentini</surname><given-names>D</given-names></name>, <name><surname>Marchetti</surname><given-names>M</given-names></name>, <name><surname>Landi</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Vitamin B6 deficiency affects antioxidant defences in rat liver and heart</article-title>. <source>Biochem Mol Biol Int</source>
<volume>46</volume>: <fpage>689</fpage>–<lpage>697</lpage>.<pub-id pub-id-type="pmid">9844729</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
